data_1q3j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q3j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.3 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 3' ' ' LYS . 74.9 mt 70.6 158.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 123.403 0.439 . . . . 0.0 111.787 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.555 ' N ' HG22 ' A' ' 2' ' ' ILE . 9.1 mtpm? 78.47 149.03 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.853 0.861 . . . . 0.0 112.292 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -71.76 56.72 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.388 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.55 0.12 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -161.86 145.9 12.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.12 137.02 50.68 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 123.568 0.542 . . . . 0.0 113.084 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' SG ' ' HG3' ' A' ' 9' ' ' GLN . 9.3 t -140.88 -50.72 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.503 0.192 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.716 ' HG2' ' HA3' ' A' ' 15' ' ' GLY . 22.7 mt-30 -135.0 70.49 70.2 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.453 0.168 . . . . 0.0 111.18 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 18.1 Cg_endo -61.5 -39.25 56.89 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.072 2.515 . . . . 0.0 113.418 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -147.12 24.47 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.28 0.562 . . . . 0.0 111.387 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.1 30.96 77.93 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.547 -0.751 . . . . 0.0 114.908 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -83.2 58.81 4.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.603 0.702 . . . . 0.0 109.807 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 62.81 49.18 3.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.373 0.606 . . . . 0.0 109.397 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.716 ' HA3' ' HG2' ' A' ' 9' ' ' GLN . . . -60.75 134.09 49.6 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.776 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -157.77 127.75 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.872 0.368 . . . . 0.0 110.301 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.4 t -95.5 148.24 22.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.195 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.07 -34.92 66.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.223 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.472 ' HB3' HG12 ' A' ' 2' ' ' ILE . 12.0 p -63.78 -29.0 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.73 30.85 14.01 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 2.7 t80 -159.93 133.15 6.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.1 t -133.1 -171.76 2.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.963 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -164.56 118.58 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.845 0.355 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 86.1 tttt -147.38 119.21 8.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.455 0.645 . . . . 0.0 110.72 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -94.8 149.75 36.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.276 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.73 57.45 1.47 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.016 2.478 . . . . 0.0 112.519 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.43 -59.72 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.26 -0.495 . . . . 0.0 111.949 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.609 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -72.59 156.4 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 t -73.74 -63.75 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.906 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -93.37 124.91 37.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.54 136.03 14.22 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.63 165.09 12.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.983 0.421 . . . . 0.0 111.953 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 98.0 m -70.61 169.91 13.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.847 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 26.4 ttp180 -151.36 142.22 22.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.666 ' HG3' ' HG2' ' A' ' 36' ' ' LYS . 38.8 ptt180 -99.3 -34.19 10.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.118 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.666 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 21.3 pttp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.138 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.493 ' CG1' ' HB2' ' A' ' 18' ' ' CYS . 54.8 mt 74.66 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.433 0.458 . . . . 0.0 110.338 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 30.1 mtpp 74.94 148.53 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.184 0.594 . . . . 0.0 110.434 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 66.2 m-80 -59.64 137.93 57.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.324 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' A' ' 32' ' ' TYR . . . 135.09 -46.91 1.01 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.582 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 10.1 t-20 -63.33 126.43 27.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.903 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.99 76.94 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 21.7 p -69.3 -44.34 71.99 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.587 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 4.2 tp60 -129.08 82.28 68.9 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.57 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 38.1 Cg_exo -57.86 -42.33 60.0 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.494 2.129 . . . . 0.0 110.971 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -162.64 -31.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.823 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.59 55.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.908 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 p -95.42 -58.22 2.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.591 0.195 . . . . 0.0 110.614 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 176.59 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 123.614 0.571 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 8' ' ' CYS . . . 81.03 53.5 3.91 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -76.03 54.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.0 m -70.73 134.73 47.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . 55.6 m -69.75 -22.69 63.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.4 p -173.77 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 111.329 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -50.59 -20.87 4.22 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.05 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' A' ' 20' ' ' GLY . 4.0 t80 72.81 115.08 0.06 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.528 0.68 . . . . 0.0 110.429 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 31.8 t -67.96 135.51 52.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.125 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -142.54 129.37 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.56 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.629 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 27.2 ttpp -140.02 120.97 14.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.684 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -85.6 144.77 40.56 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 56.3 1.87 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.622 2.215 . . . . 0.0 113.205 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.53 34.28 0.12 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.118 -1.039 . . . . 0.0 114.23 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.595 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -158.75 12.12 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.998 0.899 . . . . 0.0 112.089 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m 31.26 44.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -179.09 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.128 0.489 . . . . 0.0 111.138 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -86.62 151.26 24.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.656 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -135.82 159.69 40.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 111.413 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 62.3 m -66.73 129.18 39.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.294 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.7 -144.35 0.08 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -141.42 138.72 33.13 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.531 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 49.8 t . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.562 HG12 ' HA2' ' A' ' 20' ' ' GLY . 26.7 mt -65.57 119.51 10.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -153.55 24.68 0.52 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 59.08 121.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.797 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.815 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 65.04 23.01 69.28 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.622 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 6.1 t-20 -84.68 162.87 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.34 88.37 0.1 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.192 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.82 -33.67 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.3 tt0 -154.79 64.55 4.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.629 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 14' ' ' GLN . 73.0 Cg_endo -77.57 -44.83 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.759 2.306 . . . . 0.0 112.832 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.26 -32.78 38.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.617 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.62 -35.93 3.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.597 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -68.29 -50.52 53.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 109.881 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 18.9 tt0 -169.46 -142.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.03 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.11 -139.79 2.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.705 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -137.42 42.06 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 111.793 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 m -122.68 117.93 26.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.9 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -48.95 78.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.667 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.429 ' O ' HD12 ' A' ' 2' ' ' ILE . 48.8 m -153.71 45.93 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.562 ' HA2' HG12 ' A' ' 2' ' ' ILE . . . -73.64 -7.81 75.15 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.283 -1.326 . . . . 0.0 114.136 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 14.5 t80 67.31 74.08 0.32 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.0 109.331 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.81 124.41 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.281 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -120.47 120.14 35.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 57.2 tttm -147.3 127.65 13.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.281 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -141.46 155.85 67.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.487 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.5 113.65 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.662 2.241 . . . . 0.0 111.58 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.01 -47.13 0.52 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.496 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 2.0 p90 -110.78 151.17 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.94 -38.28 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -110.01 127.63 54.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.7 134.11 14.71 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.815 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 20.0 p90 -104.66 152.23 22.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.416 ' HB3' ' HA3' ' A' ' 20' ' ' GLY . 3.9 m -81.8 118.11 22.63 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.593 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 79.2 ttt180 -107.45 132.92 52.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.56 109.55 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.853 -179.033 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.401 HG12 ' H ' ' A' ' 19' ' ' SER . 27.1 mt 66.72 47.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 122.041 0.924 . . . . 0.0 109.899 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -88.89 131.37 35.15 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.427 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.64 62.64 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.33 -28.24 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.134 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -52.42 133.14 35.31 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.537 0.335 . . . . 0.0 110.72 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.01 83.42 0.72 Allowed Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.457 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.5 t -81.04 -39.06 26.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.877 0.37 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -127.02 71.94 75.99 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.695 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 10.1 Cg_exo -72.45 -52.0 0.19 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.793 2.329 . . . . 0.0 112.103 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -160.67 36.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.892 0.377 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.04 43.72 88.22 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.39 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 t -126.63 -35.93 2.29 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.823 -0.222 . . . . 0.0 110.613 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -167.7 128.95 1.48 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.175 0.512 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 8' ' ' CYS . . . 169.68 138.18 2.43 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -163.21 138.96 6.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.269 0.534 . . . . 0.0 111.137 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -140.31 140.58 35.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -51.03 -36.08 37.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.401 ' H ' HG12 ' A' ' 2' ' ' ILE . 25.5 p -68.27 -35.01 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.75 36.35 91.08 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 9.4 t80 -136.67 58.41 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.679 0.752 . . . . 0.0 109.601 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.6 m -82.38 136.0 35.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.012 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -114.57 134.75 54.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.863 0.363 . . . . 0.0 111.301 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 85.0 tttt -135.27 147.48 49.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.548 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 6.7 tt0 -145.67 145.1 24.4 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 25' ' ' GLN . 38.3 Cg_endo -66.37 48.03 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.283 2.656 . . . . 0.0 113.239 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.76 16.65 2.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.5 p90 -167.24 154.05 8.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.47 -56.79 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 128.11 8.3 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.425 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -80.53 152.82 28.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.215 0.531 . . . . 0.0 112.035 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.818 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.3 m -76.93 131.8 38.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.35 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 59.3 mtp180 -101.75 148.54 25.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.057 0.456 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -92.56 -38.77 11.73 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.504 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.38 0.133 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.869 HG13 ' SG ' ' A' ' 17' ' ' CYS . 29.2 mm -50.57 146.03 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' N ' HG21 ' A' ' 2' ' ' ILE . 24.6 ttmm -145.96 165.55 28.64 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -67.75 67.43 0.1 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.043 0.838 . . . . 0.0 111.241 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.9 -20.28 0.21 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 3' ' ' LYS . 3.6 m120 -63.65 136.24 57.35 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.184 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.74 139.94 41.85 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.942 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 34.6 t -113.9 -42.82 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.349 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 2.3 mm100 -154.36 77.19 5.47 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 12.5 Cg_exo -68.99 124.12 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.468 2.112 . . . . 0.0 111.042 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 69.38 -57.06 0.54 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.884 0.874 . . . . 0.0 111.338 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.19 -25.15 3.05 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 m -59.99 -39.19 84.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 111.904 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.449 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 23.5 tp60 -159.39 135.05 8.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 9' ' ' GLN . . . -170.71 138.97 5.24 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.211 -0.518 . . . . 0.0 112.01 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -141.06 141.69 34.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.869 ' SG ' HG13 ' A' ' 2' ' ' ILE . 1.7 t -149.73 127.08 11.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.06 -26.99 67.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.873 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.602 ' OG ' ' HG3' ' A' ' 35' ' ' ARG . 33.7 t -74.01 -40.07 63.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.659 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.62 47.12 12.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.539 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 28.9 t80 -144.91 70.77 1.28 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.9 m -68.62 80.09 0.28 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.803 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -70.63 94.63 1.02 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.786 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 61.1 tttm -141.85 44.98 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.344 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.581 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 74.2 mt-30 -68.65 -52.57 18.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.772 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 21.1 Cg_exo -66.78 157.93 58.77 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.174 1.916 . . . . 0.0 111.16 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.52 38.86 0.73 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 114.52 0.568 . . . . 0.0 114.52 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.786 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -81.41 151.03 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.639 0.719 . . . . 0.0 109.574 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.84 -46.45 91.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -108.14 119.4 39.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.26 139.96 17.18 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -122.46 157.43 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.928 0.864 . . . . 0.0 112.6 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 1.5 m -87.0 114.41 23.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -90.68 47.69 1.45 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.533 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.602 ' HG3' ' OG ' ' A' ' 19' ' ' SER . 13.5 ptm180 -177.19 -147.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.709 0.29 . . . . 0.0 110.72 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 35' ' ' ARG . 20.8 tptm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.688 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.303 0.097 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.805 HG23 ' HB3' ' A' ' 6' ' ' ASN . 2.1 pp -45.34 129.4 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 O-C-N 123.732 0.645 . . . . 0.0 112.178 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -86.54 45.14 1.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 35' ' ' ARG . 81.1 m-20 53.4 38.37 27.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.094 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.36 33.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.429 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB3' HG23 ' A' ' 2' ' ' ILE . 26.2 t-20 -101.03 136.44 40.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.3 119.8 20.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.495 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.738 ' SG ' ' HG3' ' A' ' 14' ' ' GLN . 42.2 t -98.4 -53.36 3.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.529 0.204 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.0 101.34 16.62 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.128 0.49 . . . . 0.0 110.591 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 59.0 Cg_endo -72.82 -36.42 4.67 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.314 2.676 . . . . 0.0 112.71 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -158.41 56.68 0.45 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.039 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.61 40.17 54.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -145.8 80.23 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.738 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.2 tt0 -64.16 115.44 4.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.19 -67.24 1.76 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.582 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -177.12 149.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 0.0 110.343 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' A' ' 2' ' ' ILE . 41.8 t -154.66 136.13 14.2 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.6 t -62.14 -45.94 91.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.141 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 p -89.86 -36.56 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.101 0.477 . . . . 0.0 110.919 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.69 19.31 60.09 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 29.3 t80 -96.8 56.94 1.51 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.642 0.734 . . . . 0.0 109.193 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.2 m -75.63 71.37 2.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.865 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' A' ' 34' ' ' ARG . 6.6 p-80 -78.13 135.96 37.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.96 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.651 ' HB2' ' HE1' ' A' ' 28' ' ' TRP . 20.0 ptmt -164.26 148.43 9.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.16 0.505 . . . . 0.0 111.635 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' C ' ' H ' ' A' ' 27' ' ' GLY . 95.8 mm-40 -114.41 155.67 45.52 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.464 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.03 32.01 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.019 2.479 . . . . 0.0 113.705 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 25' ' ' GLN . . . -104.99 -50.56 0.93 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.704 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.651 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 p90 -90.71 -176.07 4.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.632 0.253 . . . . 0.0 110.618 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.85 -79.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -92.93 134.63 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 24' ' ' LYS . . . -78.59 156.07 42.25 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -133.15 148.69 52.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.806 0.803 . . . . 0.0 111.76 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 57.1 m -73.49 138.62 45.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.464 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . 47.6 ttt180 -119.94 137.55 53.98 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.451 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 79.3 mtm180 -137.32 120.14 16.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.008 0.432 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.248 0.997 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.845 179.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.384 0.135 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.921 HD12 ' HB2' ' A' ' 19' ' ' SER . 43.7 mt 64.52 48.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 122.188 0.994 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -141.1 135.91 31.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.637 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 19.7 p30 -66.74 138.06 57.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.29 46.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.101 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -66.67 130.51 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.75 134.53 44.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.345 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.545 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.3 p -132.59 -21.42 2.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.699 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.462 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 71.9 mm-40 -136.07 85.41 28.32 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 111.043 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 60.1 Cg_endo -74.26 76.22 3.14 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.867 2.378 . . . . 0.0 111.498 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.5 t30 75.3 -56.22 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.18 92.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 p -159.03 -58.51 0.07 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.63 0.252 . . . . 0.0 110.807 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -171.33 133.65 0.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.73 149.79 5.8 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -177.2 146.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 110.735 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.21 143.57 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.547 ' SG ' HG13 ' A' ' 2' ' ' ILE . 10.0 p -67.5 -52.83 34.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.916 0.326 . . . . 0.0 111.45 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.921 ' HB2' HD12 ' A' ' 2' ' ' ILE . 15.7 m -142.64 61.25 1.43 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -125.35 1.65 Allowed Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.03 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -160.33 117.97 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.584 0.231 . . . . 0.0 110.461 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' SG ' ' HG2' ' A' ' 9' ' ' GLN . 48.8 t -82.98 145.64 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -143.71 120.73 11.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.243 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.621 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 50.8 tttp -157.88 125.54 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 88.3 mt-30 -121.34 -62.84 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 41.5 Cg_endo -85.24 -156.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.541 1.494 . . . . 0.0 110.327 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 -52.1 4.12 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.853 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.606 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 27.07 50.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.419 1.488 . . . . 0.0 114.51 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.4 t 70.75 -57.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.344 0.657 . . . . 0.0 111.849 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.73 146.6 2.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.611 0.243 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.621 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -63.92 140.59 44.09 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -123.78 148.68 46.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 112.241 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 85.8 m -70.37 132.15 45.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -98.21 22.84 8.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 72.01 -51.1 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.265 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.724 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.527 0.203 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.443 HD13 ' C ' ' A' ' 19' ' ' SER . 78.6 mt 70.16 120.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.943 0.777 . . . . 0.0 112.787 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -152.09 121.17 6.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 81.1 m-20 -77.06 60.25 1.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.393 0.616 . . . . 0.0 111.07 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.18 -40.48 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.707 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -63.83 134.74 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . -70.2 110.05 3.14 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.343 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 p -84.94 -38.27 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 0.0 109.594 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.626 ' HB3' ' HD2' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -123.71 77.37 56.43 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.713 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 3.9 Cg_exo -78.26 -44.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.526 2.818 . . . . 0.0 114.103 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -158.49 55.36 0.44 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.76 38.79 41.54 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.71 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.508 ' OG ' ' HD2' ' A' ' 10' ' ' PRO . 25.6 p -100.0 37.23 1.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 122.46 -0.435 . . . . 0.0 110.008 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 69.85 -59.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.164 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.77 -142.0 9.05 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.75 -138.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.51 64.06 1.94 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.4 m -38.28 -38.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.443 ' C ' HD13 ' A' ' 2' ' ' ILE . 9.1 t -138.34 45.77 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 110.031 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.41 -139.17 3.21 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.547 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.473 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 25.2 t80 -143.88 122.53 12.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.884 0.374 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 51.6 t -86.34 118.04 25.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -103.2 124.06 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.128 0.49 . . . . 0.0 111.196 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HD2' ' HB3' ' A' ' 9' ' ' GLN . 61.8 tttm -142.54 137.87 30.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -155.86 154.05 27.07 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.65 117.51 3.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.923 2.415 . . . . 0.0 112.527 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.54 -60.24 0.4 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.302 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -93.23 159.43 15.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.94 -49.69 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.793 0.33 . . . . 0.0 111.808 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.489 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -115.28 132.45 56.61 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.417 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . -75.17 150.34 40.5 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -127.41 155.66 43.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 118.003 0.901 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 64.8 m -64.02 133.32 52.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -123.82 51.14 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HB3' ' H ' ' A' ' 36' ' ' LYS . 59.6 ttt180 64.78 -98.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.5 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 21' ' ' TYR . 26.8 tptp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.196 -0.906 . . . . 0.0 109.717 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.831 HG23 ' HD3' ' A' ' 35' ' ' ARG . 28.7 mt 67.71 72.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.093 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -155.43 145.8 21.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -60.59 146.03 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.34 -38.78 3.06 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.989 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -69.09 136.48 52.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.68 0.276 . . . . 0.0 110.9 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.52 85.91 0.62 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 3.9 t -54.28 -44.29 71.77 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.224 0.61 . . . . 0.0 111.675 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.438 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 38.3 tt0 -145.52 87.89 6.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.658 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.38 -43.1 2.31 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.825 2.35 . . . . 0.0 111.739 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -159.69 40.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.52 42.21 99.72 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.597 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -64.43 -52.25 59.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.583 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -60.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.55 103.48 0.19 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.901 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.1 -50.3 64.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.265 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -86.66 144.94 26.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.57 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.429 ' O ' HD13 ' A' ' 2' ' ' ILE . 14.6 m -73.3 71.75 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.874 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.7 m 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 109.715 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 18.12 54.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.955 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.2 t80 58.9 92.72 0.04 OUTLIER 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.07 0.938 . . . . 0.0 110.618 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.8 134.16 39.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.733 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.1 118.45 24.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.579 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 25.4 ttpp -136.59 124.82 23.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.622 0.725 . . . . 0.0 112.48 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.9 139.27 24.59 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.67 52.53 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.773 2.316 . . . . 0.0 113.339 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.5 39.58 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.128 -1.035 . . . . 0.0 114.183 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.579 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.5 OUTLIER -151.31 28.8 0.65 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.081 0.94 . . . . 0.0 112.429 178.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.4 t 67.8 -53.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.14 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.04 133.81 12.11 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.354 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -86.78 155.7 20.21 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.464 0.306 . . . . 0.0 110.802 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 33.5 m -75.35 122.18 23.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -83.14 66.21 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.071 0.462 . . . . 0.0 111.773 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.831 ' HD3' HG23 ' A' ' 2' ' ' ILE . 11.8 tpt180 -76.52 61.7 1.79 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.788 0.804 . . . . 0.0 109.6 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.142 -0.933 . . . . 0.0 109.831 -179.338 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.731 HG13 ' HG2' ' A' ' 35' ' ' ARG . 5.2 tp -83.34 112.11 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.319 0.58 . . . . 0.0 110.259 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -166.56 137.41 3.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.069 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 18.8 p30 -69.65 133.97 48.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -31.17 8.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.282 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.09 140.22 57.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.723 0.297 . . . . 0.0 110.337 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 95.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.525 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 11.9 t -83.25 -46.62 12.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.179 0.514 . . . . 0.0 109.636 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.434 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 83.2 mt-30 -140.57 79.38 20.16 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.225 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.923 ' HA ' ' HB1' ' A' ' 30' ' ' ALA . 7.2 Cg_exo -74.31 51.48 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 113.518 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 t30 58.81 71.06 0.61 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 111.611 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.1 55.27 5.3 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.5 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 58.4 m -149.96 148.09 28.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -57.42 135.39 56.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 0.0 111.735 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.47 126.85 1.1 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -142.98 127.23 17.6 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 m -78.97 131.75 36.44 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.621 ' HB2' HG23 ' A' ' 2' ' ' ILE . 89.8 m -53.84 -46.52 71.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.9 p -72.68 -47.54 46.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.037 0.446 . . . . 0.0 110.33 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.9 2.14 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.489 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -66.16 126.99 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.369 0.604 . . . . 0.0 112.463 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.92 145.51 49.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.546 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -124.43 117.8 25.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.718 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 65.7 tttm -155.21 114.68 3.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 68.0 mt-30 -147.39 -51.98 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.503 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 24.5 Cg_exo -63.23 159.28 40.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.836 1.691 . . . . 0.0 111.442 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.57 45.47 2.4 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.762 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.718 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -78.74 167.39 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 111.068 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.5 -28.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.411 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.923 ' HB1' ' HA ' ' A' ' 10' ' ' PRO . . . -157.58 136.22 11.36 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 147.1 30.5 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -127.02 159.01 35.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.888 0.844 . . . . 0.0 112.867 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 58.0 m -78.67 178.76 7.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.281 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -159.83 133.62 7.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.731 ' HG2' HG13 ' A' ' 2' ' ' ILE . 75.7 mtp180 -84.72 -154.38 0.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.808 0.337 . . . . 0.0 110.566 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.134 179.348 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.3 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 3' ' ' LYS . 74.9 mt 70.6 158.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 123.403 0.439 . . . . 0.0 111.787 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.555 ' N ' HG22 ' A' ' 2' ' ' ILE . 9.1 mtpm? 78.47 149.03 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.853 0.861 . . . . 0.0 112.292 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -71.76 56.72 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.388 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.55 0.12 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -161.86 145.9 12.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.12 137.02 50.68 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 123.568 0.542 . . . . 0.0 113.084 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' SG ' ' HG3' ' A' ' 9' ' ' GLN . 9.3 t -140.88 -50.72 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.503 0.192 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.716 ' HG2' ' HA3' ' A' ' 15' ' ' GLY . 22.7 mt-30 -135.0 70.49 70.2 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.453 0.168 . . . . 0.0 111.18 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 18.1 Cg_endo -61.5 -39.25 56.89 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.072 2.515 . . . . 0.0 113.418 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -147.12 24.47 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.28 0.562 . . . . 0.0 111.387 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.1 30.96 77.93 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.547 -0.751 . . . . 0.0 114.908 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -83.2 58.81 4.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.603 0.702 . . . . 0.0 109.807 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 62.81 49.18 3.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.373 0.606 . . . . 0.0 109.397 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.716 ' HA3' ' HG2' ' A' ' 9' ' ' GLN . . . -60.75 134.09 49.6 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.776 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -157.77 127.75 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.872 0.368 . . . . 0.0 110.301 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.4 t -95.5 148.24 22.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.195 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.07 -34.92 66.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.223 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.472 ' HB3' HG12 ' A' ' 2' ' ' ILE . 12.0 p -63.78 -29.0 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.73 30.85 14.01 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 2.7 t80 -159.93 133.15 6.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.1 t -133.1 -171.76 2.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.963 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -164.56 118.58 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.845 0.355 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 86.1 tttt -147.38 119.21 8.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.455 0.645 . . . . 0.0 110.72 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -94.8 149.75 36.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.276 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.73 57.45 1.47 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.016 2.478 . . . . 0.0 112.519 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.43 -59.72 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.26 -0.495 . . . . 0.0 111.949 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.609 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -72.59 156.4 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 t -73.74 -63.75 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.906 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -93.37 124.91 37.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.54 136.03 14.22 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.63 165.09 12.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.983 0.421 . . . . 0.0 111.953 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 98.0 m -70.61 169.91 13.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.847 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 26.4 ttp180 -151.36 142.22 22.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.666 ' HG3' ' HG2' ' A' ' 36' ' ' LYS . 38.8 ptt180 -99.3 -34.19 10.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.118 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.666 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 21.3 pttp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.138 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.493 ' CG1' ' HB2' ' A' ' 18' ' ' CYS . 54.8 mt 74.66 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.433 0.458 . . . . 0.0 110.338 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 30.1 mtpp 74.94 148.53 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.184 0.594 . . . . 0.0 110.434 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 66.2 m-80 -59.64 137.93 57.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.324 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' A' ' 32' ' ' TYR . . . 135.09 -46.91 1.01 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.582 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 10.1 t-20 -63.33 126.43 27.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.903 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.99 76.94 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 21.7 p -69.3 -44.34 71.99 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.587 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 4.2 tp60 -129.08 82.28 68.9 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.57 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 38.1 Cg_exo -57.86 -42.33 60.0 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.494 2.129 . . . . 0.0 110.971 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -162.64 -31.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.823 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.59 55.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.908 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 p -95.42 -58.22 2.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.591 0.195 . . . . 0.0 110.614 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 176.59 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 123.614 0.571 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 8' ' ' CYS . . . 81.03 53.5 3.91 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -76.03 54.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.0 m -70.73 134.73 47.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . 55.6 m -69.75 -22.69 63.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.4 p -173.77 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 111.329 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -50.59 -20.87 4.22 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.05 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' A' ' 20' ' ' GLY . 4.0 t80 72.81 115.08 0.06 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.528 0.68 . . . . 0.0 110.429 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 31.8 t -67.96 135.51 52.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.125 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -142.54 129.37 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.56 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.629 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 27.2 ttpp -140.02 120.97 14.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.684 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -85.6 144.77 40.56 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 56.3 1.87 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.622 2.215 . . . . 0.0 113.205 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.53 34.28 0.12 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.118 -1.039 . . . . 0.0 114.23 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.595 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -158.75 12.12 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.998 0.899 . . . . 0.0 112.089 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m 31.26 44.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -179.09 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.128 0.489 . . . . 0.0 111.138 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -86.62 151.26 24.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.656 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -135.82 159.69 40.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 111.413 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 62.3 m -66.73 129.18 39.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.294 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.7 -144.35 0.08 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -141.42 138.72 33.13 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.531 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 49.8 t . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.562 HG12 ' HA2' ' A' ' 20' ' ' GLY . 26.7 mt -65.57 119.51 10.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -153.55 24.68 0.52 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 59.08 121.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.797 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.815 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 65.04 23.01 69.28 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.622 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 6.1 t-20 -84.68 162.87 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.34 88.37 0.1 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.192 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.82 -33.67 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.3 tt0 -154.79 64.55 4.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.629 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 14' ' ' GLN . 73.0 Cg_endo -77.57 -44.83 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.759 2.306 . . . . 0.0 112.832 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.26 -32.78 38.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.617 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.62 -35.93 3.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.597 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -68.29 -50.52 53.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 109.881 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 18.9 tt0 -169.46 -142.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.03 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.11 -139.79 2.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.705 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -137.42 42.06 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 111.793 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 m -122.68 117.93 26.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.9 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -48.95 78.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.667 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.429 ' O ' HD12 ' A' ' 2' ' ' ILE . 48.8 m -153.71 45.93 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.562 ' HA2' HG12 ' A' ' 2' ' ' ILE . . . -73.64 -7.81 75.15 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.283 -1.326 . . . . 0.0 114.136 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.593 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 14.5 t80 67.31 74.08 0.32 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.0 109.331 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.81 124.41 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.281 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -120.47 120.14 35.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.496 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 57.2 tttm -147.3 127.65 13.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.281 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -141.46 155.85 67.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.487 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.5 113.65 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.662 2.241 . . . . 0.0 111.58 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.01 -47.13 0.52 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.496 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 2.0 p90 -110.78 151.17 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.94 -38.28 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -110.01 127.63 54.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.7 134.11 14.71 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.815 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 20.0 p90 -104.66 152.23 22.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.416 ' HB3' ' HA3' ' A' ' 20' ' ' GLY . 3.9 m -81.8 118.11 22.63 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.593 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 79.2 ttt180 -107.45 132.92 52.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.56 109.55 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.853 -179.033 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.401 HG12 ' H ' ' A' ' 19' ' ' SER . 27.1 mt 66.72 47.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 122.041 0.924 . . . . 0.0 109.899 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -88.89 131.37 35.15 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.427 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.64 62.64 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.33 -28.24 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.134 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -52.42 133.14 35.31 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.537 0.335 . . . . 0.0 110.72 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.01 83.42 0.72 Allowed Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.457 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.818 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.5 t -81.04 -39.06 26.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.877 0.37 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -127.02 71.94 75.99 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.695 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 10.1 Cg_exo -72.45 -52.0 0.19 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.793 2.329 . . . . 0.0 112.103 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -160.67 36.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.892 0.377 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.04 43.72 88.22 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.39 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 t -126.63 -35.93 2.29 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.823 -0.222 . . . . 0.0 110.613 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -167.7 128.95 1.48 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.175 0.512 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 8' ' ' CYS . . . 169.68 138.18 2.43 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -163.21 138.96 6.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.269 0.534 . . . . 0.0 111.137 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -140.31 140.58 35.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -51.03 -36.08 37.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.401 ' H ' HG12 ' A' ' 2' ' ' ILE . 25.5 p -68.27 -35.01 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.75 36.35 91.08 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 9.4 t80 -136.67 58.41 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.679 0.752 . . . . 0.0 109.601 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.6 m -82.38 136.0 35.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.012 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -114.57 134.75 54.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.863 0.363 . . . . 0.0 111.301 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 85.0 tttt -135.27 147.48 49.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.548 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 6.7 tt0 -145.67 145.1 24.4 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 25' ' ' GLN . 38.3 Cg_endo -66.37 48.03 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.283 2.656 . . . . 0.0 113.239 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.76 16.65 2.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.5 p90 -167.24 154.05 8.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.47 -56.79 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 128.11 8.3 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.425 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -80.53 152.82 28.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.215 0.531 . . . . 0.0 112.035 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.818 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.3 m -76.93 131.8 38.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.35 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 59.3 mtp180 -101.75 148.54 25.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.057 0.456 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -92.56 -38.77 11.73 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.504 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.38 0.133 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.869 HG13 ' SG ' ' A' ' 17' ' ' CYS . 29.2 mm -50.57 146.03 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' N ' HG21 ' A' ' 2' ' ' ILE . 24.6 ttmm -145.96 165.55 28.64 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -67.75 67.43 0.1 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.043 0.838 . . . . 0.0 111.241 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.9 -20.28 0.21 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.4 ' HB2' ' H ' ' A' ' 3' ' ' LYS . 3.6 m120 -63.65 136.24 57.35 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.184 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.74 139.94 41.85 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.942 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 34.6 t -113.9 -42.82 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.349 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.547 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 2.3 mm100 -154.36 77.19 5.47 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 12.5 Cg_exo -68.99 124.12 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.468 2.112 . . . . 0.0 111.042 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 69.38 -57.06 0.54 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.884 0.874 . . . . 0.0 111.338 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.19 -25.15 3.05 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 m -59.99 -39.19 84.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 111.904 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.449 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 23.5 tp60 -159.39 135.05 8.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 9' ' ' GLN . . . -170.71 138.97 5.24 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.211 -0.518 . . . . 0.0 112.01 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -141.06 141.69 34.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.869 ' SG ' HG13 ' A' ' 2' ' ' ILE . 1.7 t -149.73 127.08 11.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.06 -26.99 67.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.873 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.602 ' OG ' ' HG3' ' A' ' 35' ' ' ARG . 33.7 t -74.01 -40.07 63.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.659 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.62 47.12 12.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.539 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 28.9 t80 -144.91 70.77 1.28 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.9 m -68.62 80.09 0.28 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.803 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -70.63 94.63 1.02 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.786 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 61.1 tttm -141.85 44.98 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.344 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.581 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 74.2 mt-30 -68.65 -52.57 18.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.772 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 21.1 Cg_exo -66.78 157.93 58.77 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.174 1.916 . . . . 0.0 111.16 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.52 38.86 0.73 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 114.52 0.568 . . . . 0.0 114.52 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.786 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -81.41 151.03 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.639 0.719 . . . . 0.0 109.574 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.84 -46.45 91.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -108.14 119.4 39.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.26 139.96 17.18 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -122.46 157.43 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.928 0.864 . . . . 0.0 112.6 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 1.5 m -87.0 114.41 23.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -90.68 47.69 1.45 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.533 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.602 ' HG3' ' OG ' ' A' ' 19' ' ' SER . 13.5 ptm180 -177.19 -147.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.709 0.29 . . . . 0.0 110.72 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 35' ' ' ARG . 20.8 tptm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.688 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.303 0.097 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.805 HG23 ' HB3' ' A' ' 6' ' ' ASN . 2.1 pp -45.34 129.4 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 O-C-N 123.732 0.645 . . . . 0.0 112.178 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -86.54 45.14 1.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 35' ' ' ARG . 81.1 m-20 53.4 38.37 27.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.094 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.36 33.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.429 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.805 ' HB3' HG23 ' A' ' 2' ' ' ILE . 26.2 t-20 -101.03 136.44 40.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.3 119.8 20.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.495 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.738 ' SG ' ' HG3' ' A' ' 14' ' ' GLN . 42.2 t -98.4 -53.36 3.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.529 0.204 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.0 101.34 16.62 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.128 0.49 . . . . 0.0 110.591 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 59.0 Cg_endo -72.82 -36.42 4.67 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.314 2.676 . . . . 0.0 112.71 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -158.41 56.68 0.45 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.039 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.61 40.17 54.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -145.8 80.23 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.738 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.2 tt0 -64.16 115.44 4.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.19 -67.24 1.76 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.582 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -177.12 149.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 0.0 110.343 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' A' ' 2' ' ' ILE . 41.8 t -154.66 136.13 14.2 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.6 t -62.14 -45.94 91.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.141 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 p -89.86 -36.56 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.101 0.477 . . . . 0.0 110.919 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.69 19.31 60.09 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 29.3 t80 -96.8 56.94 1.51 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.642 0.734 . . . . 0.0 109.193 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.2 m -75.63 71.37 2.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.865 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' A' ' 34' ' ' ARG . 6.6 p-80 -78.13 135.96 37.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.96 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.651 ' HB2' ' HE1' ' A' ' 28' ' ' TRP . 20.0 ptmt -164.26 148.43 9.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.16 0.505 . . . . 0.0 111.635 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' C ' ' H ' ' A' ' 27' ' ' GLY . 95.8 mm-40 -114.41 155.67 45.52 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.464 178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.03 32.01 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.019 2.479 . . . . 0.0 113.705 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 25' ' ' GLN . . . -104.99 -50.56 0.93 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.704 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.651 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 p90 -90.71 -176.07 4.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.632 0.253 . . . . 0.0 110.618 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.85 -79.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -92.93 134.63 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 24' ' ' LYS . . . -78.59 156.07 42.25 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -133.15 148.69 52.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.806 0.803 . . . . 0.0 111.76 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 57.1 m -73.49 138.62 45.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.464 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . 47.6 ttt180 -119.94 137.55 53.98 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.451 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 79.3 mtm180 -137.32 120.14 16.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.008 0.432 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.248 0.997 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.845 179.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.384 0.135 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.921 HD12 ' HB2' ' A' ' 19' ' ' SER . 43.7 mt 64.52 48.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 122.188 0.994 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -141.1 135.91 31.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.637 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.704 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 19.7 p30 -66.74 138.06 57.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.29 46.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.101 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -66.67 130.51 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.75 134.53 44.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.345 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.545 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.3 p -132.59 -21.42 2.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.699 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.462 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 71.9 mm-40 -136.07 85.41 28.32 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 111.043 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 60.1 Cg_endo -74.26 76.22 3.14 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.867 2.378 . . . . 0.0 111.498 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.5 t30 75.3 -56.22 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.18 92.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 p -159.03 -58.51 0.07 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.63 0.252 . . . . 0.0 110.807 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -171.33 133.65 0.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.73 149.79 5.8 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -177.2 146.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 110.735 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.21 143.57 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.547 ' SG ' HG13 ' A' ' 2' ' ' ILE . 10.0 p -67.5 -52.83 34.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.916 0.326 . . . . 0.0 111.45 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.921 ' HB2' HD12 ' A' ' 2' ' ' ILE . 15.7 m -142.64 61.25 1.43 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -125.35 1.65 Allowed Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.03 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -160.33 117.97 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.584 0.231 . . . . 0.0 110.461 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' SG ' ' HG2' ' A' ' 9' ' ' GLN . 48.8 t -82.98 145.64 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -143.71 120.73 11.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.243 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.621 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 50.8 tttp -157.88 125.54 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 88.3 mt-30 -121.34 -62.84 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 41.5 Cg_endo -85.24 -156.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.541 1.494 . . . . 0.0 110.327 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 -52.1 4.12 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.853 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.606 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 27.07 50.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.419 1.488 . . . . 0.0 114.51 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.4 t 70.75 -57.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.344 0.657 . . . . 0.0 111.849 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.73 146.6 2.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.611 0.243 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.621 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -63.92 140.59 44.09 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -123.78 148.68 46.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 112.241 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 85.8 m -70.37 132.15 45.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -98.21 22.84 8.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 72.01 -51.1 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.265 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.724 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.527 0.203 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.443 HD13 ' C ' ' A' ' 19' ' ' SER . 78.6 mt 70.16 120.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.943 0.777 . . . . 0.0 112.787 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -152.09 121.17 6.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 81.1 m-20 -77.06 60.25 1.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.393 0.616 . . . . 0.0 111.07 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.18 -40.48 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.707 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -63.83 134.74 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . -70.2 110.05 3.14 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.343 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 p -84.94 -38.27 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 0.0 109.594 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.626 ' HB3' ' HD2' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -123.71 77.37 56.43 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.713 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 3.9 Cg_exo -78.26 -44.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.526 2.818 . . . . 0.0 114.103 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -158.49 55.36 0.44 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.76 38.79 41.54 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.71 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.508 ' OG ' ' HD2' ' A' ' 10' ' ' PRO . 25.6 p -100.0 37.23 1.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 122.46 -0.435 . . . . 0.0 110.008 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 69.85 -59.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.164 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.77 -142.0 9.05 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.75 -138.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.51 64.06 1.94 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.4 m -38.28 -38.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.443 ' C ' HD13 ' A' ' 2' ' ' ILE . 9.1 t -138.34 45.77 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 110.031 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.41 -139.17 3.21 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.547 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.473 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 25.2 t80 -143.88 122.53 12.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.884 0.374 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 51.6 t -86.34 118.04 25.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -103.2 124.06 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.128 0.49 . . . . 0.0 111.196 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.626 ' HD2' ' HB3' ' A' ' 9' ' ' GLN . 61.8 tttm -142.54 137.87 30.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -155.86 154.05 27.07 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.65 117.51 3.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.923 2.415 . . . . 0.0 112.527 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.54 -60.24 0.4 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.302 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -93.23 159.43 15.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.94 -49.69 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.793 0.33 . . . . 0.0 111.808 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.489 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -115.28 132.45 56.61 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.417 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . -75.17 150.34 40.5 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -127.41 155.66 43.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 118.003 0.901 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 64.8 m -64.02 133.32 52.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -123.82 51.14 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.408 ' HB3' ' H ' ' A' ' 36' ' ' LYS . 59.6 ttt180 64.78 -98.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.5 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 21' ' ' TYR . 26.8 tptp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.196 -0.906 . . . . 0.0 109.717 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.831 HG23 ' HD3' ' A' ' 35' ' ' ARG . 28.7 mt 67.71 72.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.093 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -155.43 145.8 21.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -60.59 146.03 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.34 -38.78 3.06 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.989 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -69.09 136.48 52.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.68 0.276 . . . . 0.0 110.9 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.52 85.91 0.62 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 3.9 t -54.28 -44.29 71.77 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.224 0.61 . . . . 0.0 111.675 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.438 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 38.3 tt0 -145.52 87.89 6.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.658 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.38 -43.1 2.31 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.825 2.35 . . . . 0.0 111.739 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -159.69 40.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.52 42.21 99.72 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.597 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -64.43 -52.25 59.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.583 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -60.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.55 103.48 0.19 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.901 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.1 -50.3 64.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.265 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -86.66 144.94 26.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.57 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.429 ' O ' HD13 ' A' ' 2' ' ' ILE . 14.6 m -73.3 71.75 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.874 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.7 m 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 109.715 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 18.12 54.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.955 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.2 t80 58.9 92.72 0.04 OUTLIER 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.07 0.938 . . . . 0.0 110.618 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.8 134.16 39.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.733 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.1 118.45 24.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.579 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 25.4 ttpp -136.59 124.82 23.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.622 0.725 . . . . 0.0 112.48 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.9 139.27 24.59 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.67 52.53 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.773 2.316 . . . . 0.0 113.339 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.5 39.58 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.128 -1.035 . . . . 0.0 114.183 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.579 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.5 OUTLIER -151.31 28.8 0.65 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.081 0.94 . . . . 0.0 112.429 178.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.4 t 67.8 -53.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.14 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.04 133.81 12.11 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.354 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -86.78 155.7 20.21 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.464 0.306 . . . . 0.0 110.802 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 33.5 m -75.35 122.18 23.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -83.14 66.21 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.071 0.462 . . . . 0.0 111.773 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.831 ' HD3' HG23 ' A' ' 2' ' ' ILE . 11.8 tpt180 -76.52 61.7 1.79 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.788 0.804 . . . . 0.0 109.6 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.142 -0.933 . . . . 0.0 109.831 -179.338 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.731 HG13 ' HG2' ' A' ' 35' ' ' ARG . 5.2 tp -83.34 112.11 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.319 0.58 . . . . 0.0 110.259 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -166.56 137.41 3.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.069 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.652 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 18.8 p30 -69.65 133.97 48.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -31.17 8.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.282 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.09 140.22 57.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.723 0.297 . . . . 0.0 110.337 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 95.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.525 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 11.9 t -83.25 -46.62 12.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.179 0.514 . . . . 0.0 109.636 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.434 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 83.2 mt-30 -140.57 79.38 20.16 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.225 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.923 ' HA ' ' HB1' ' A' ' 30' ' ' ALA . 7.2 Cg_exo -74.31 51.48 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 113.518 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 t30 58.81 71.06 0.61 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 111.611 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.1 55.27 5.3 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.5 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 58.4 m -149.96 148.09 28.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -57.42 135.39 56.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 0.0 111.735 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.47 126.85 1.1 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -142.98 127.23 17.6 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 m -78.97 131.75 36.44 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.621 ' HB2' HG23 ' A' ' 2' ' ' ILE . 89.8 m -53.84 -46.52 71.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.9 p -72.68 -47.54 46.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.037 0.446 . . . . 0.0 110.33 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.9 2.14 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.489 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -66.16 126.99 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.369 0.604 . . . . 0.0 112.463 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.92 145.51 49.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.546 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -124.43 117.8 25.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.718 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 65.7 tttm -155.21 114.68 3.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.521 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 68.0 mt-30 -147.39 -51.98 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.503 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 24.5 Cg_exo -63.23 159.28 40.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.836 1.691 . . . . 0.0 111.442 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.57 45.47 2.4 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.762 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.718 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -78.74 167.39 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 111.068 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.5 -28.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.411 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.923 ' HB1' ' HA ' ' A' ' 10' ' ' PRO . . . -157.58 136.22 11.36 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 147.1 30.5 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -127.02 159.01 35.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.888 0.844 . . . . 0.0 112.867 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.652 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 58.0 m -78.67 178.76 7.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.281 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -159.83 133.62 7.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.731 ' HG2' HG13 ' A' ' 2' ' ' ILE . 75.7 mtp180 -84.72 -154.38 0.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.808 0.337 . . . . 0.0 110.566 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.134 179.348 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.3 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 74.9 mt 70.6 158.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 123.403 0.439 . . . . 0.0 111.787 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 9.1 mtpm? 78.47 149.03 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.853 0.861 . . . . 0.0 112.292 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 77.9 m-20 -71.76 56.72 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.388 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.55 0.12 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -161.86 145.9 12.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.12 137.02 50.68 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 123.568 0.542 . . . . 0.0 113.084 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 9' ' ' GLN . 9.3 t -140.88 -50.72 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.503 0.192 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.735 ' HG2' ' HA3' ' A' ' 15' ' ' GLY . 78.7 mt-30 -135.0 70.49 70.2 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.453 0.168 . . . . 0.0 111.18 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 18.1 Cg_endo -61.5 -39.25 56.89 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.072 2.515 . . . . 0.0 113.418 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -147.12 24.47 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.28 0.562 . . . . 0.0 111.387 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.1 30.96 77.93 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.547 -0.751 . . . . 0.0 114.908 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -83.2 58.81 4.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.603 0.702 . . . . 0.0 109.807 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 62.81 49.18 3.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.373 0.606 . . . . 0.0 109.397 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.735 ' HA3' ' HG2' ' A' ' 9' ' ' GLN . . . -60.75 134.09 49.6 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.776 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -157.77 127.75 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.872 0.368 . . . . 0.0 110.301 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.4 t -95.5 148.24 22.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.195 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.07 -34.92 66.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.223 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' HG12 ' A' ' 2' ' ' ILE . 12.0 p -63.78 -29.0 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.73 30.85 14.01 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 2.7 t80 -159.93 133.15 6.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.1 t -133.1 -171.76 2.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.963 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -164.56 118.58 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.845 0.355 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.632 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 86.1 tttt -147.38 119.21 8.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.455 0.645 . . . . 0.0 110.72 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -94.8 149.75 36.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.276 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.73 57.45 1.47 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.016 2.478 . . . . 0.0 112.519 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.43 -59.72 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.26 -0.495 . . . . 0.0 111.949 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.632 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -72.59 156.4 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 t -73.74 -63.75 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.906 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -93.37 124.91 37.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.54 136.03 14.22 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.63 165.09 12.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.983 0.421 . . . . 0.0 111.953 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 98.0 m -70.61 169.91 13.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.847 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 26.4 ttp180 -151.36 142.22 22.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.684 ' HG3' ' HG2' ' A' ' 36' ' ' LYS . 38.8 ptt180 -99.3 -34.19 10.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.118 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.684 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 21.3 pttp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.138 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CG1' ' HB2' ' A' ' 18' ' ' CYS . 54.8 mt 74.66 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.433 0.458 . . . . 0.0 110.338 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HG3' HG22 ' A' ' 2' ' ' ILE . 30.1 mtpp 74.94 148.53 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.184 0.594 . . . . 0.0 110.434 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 66.2 m-80 -59.64 137.93 57.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.324 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 32' ' ' TYR . . . 135.09 -46.91 1.01 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.582 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 10.1 t-20 -63.33 126.43 27.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.903 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.99 76.94 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.544 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 21.7 p -69.3 -44.34 71.99 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.587 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 4.2 tp60 -129.08 82.28 68.9 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.57 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 38.1 Cg_exo -57.86 -42.33 60.0 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.494 2.129 . . . . 0.0 110.971 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -162.64 -31.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.823 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.59 55.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.908 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 p -95.42 -58.22 2.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.591 0.195 . . . . 0.0 110.614 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 176.59 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 123.614 0.571 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 8' ' ' CYS . . . 81.03 53.5 3.91 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -76.03 54.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.0 m -70.73 134.73 47.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . 55.6 m -69.75 -22.69 63.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.4 p -173.77 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 111.329 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -50.59 -20.87 4.22 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.05 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 20' ' ' GLY . 4.0 t80 72.81 115.08 0.06 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.528 0.68 . . . . 0.0 110.429 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 31.8 t -67.96 135.51 52.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.125 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -142.54 129.37 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.56 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.656 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 27.2 ttpp -140.02 120.97 14.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.684 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -85.6 144.77 40.56 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 56.3 1.87 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.622 2.215 . . . . 0.0 113.205 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.53 34.28 0.12 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.118 -1.039 . . . . 0.0 114.23 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.625 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -158.75 12.12 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.998 0.899 . . . . 0.0 112.089 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m 31.26 44.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -179.09 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.128 0.489 . . . . 0.0 111.138 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -86.62 151.26 24.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.656 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -135.82 159.69 40.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 111.413 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 62.3 m -66.73 129.18 39.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.294 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.7 -144.35 0.08 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -141.42 138.72 33.13 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.531 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 49.8 t . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.564 HG12 ' HA2' ' A' ' 20' ' ' GLY . 26.7 mt -65.57 119.51 10.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -153.55 24.68 0.52 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 59.08 121.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.797 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.816 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 65.04 23.01 69.28 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.622 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 6.1 t-20 -84.68 162.87 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.34 88.37 0.1 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.192 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.82 -33.67 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 55.8 tt0 -154.79 64.55 4.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.629 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 14' ' ' GLN . 73.0 Cg_endo -77.57 -44.83 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.759 2.306 . . . . 0.0 112.832 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.26 -32.78 38.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.617 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.62 -35.93 3.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.597 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -68.29 -50.52 53.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 109.881 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 18.9 tt0 -169.46 -142.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.03 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.11 -139.79 2.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.705 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -137.42 42.06 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 111.793 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 m -122.68 117.93 26.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.9 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -48.95 78.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.667 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -153.71 45.93 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA2' HG12 ' A' ' 2' ' ' ILE . . . -73.64 -7.81 75.15 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.283 -1.326 . . . . 0.0 114.136 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 14.5 t80 67.31 74.08 0.32 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.0 109.331 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.81 124.41 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.281 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -120.47 120.14 35.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 57.2 tttm -147.3 127.65 13.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.281 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -141.46 155.85 67.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.487 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.5 113.65 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.662 2.241 . . . . 0.0 111.58 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.01 -47.13 0.52 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.538 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 2.0 p90 -110.78 151.17 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.94 -38.28 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.01 127.63 54.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.7 134.11 14.71 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.816 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 20.0 p90 -104.66 152.23 22.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 20' ' ' GLY . 3.9 m -81.8 118.11 22.63 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.601 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 79.2 ttt180 -107.45 132.92 52.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.56 109.55 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.853 -179.033 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.673 HG22 ' HG2' ' A' ' 35' ' ' ARG . 27.1 mt 66.72 47.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 122.041 0.924 . . . . 0.0 109.899 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -88.89 131.37 35.15 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.427 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -72.64 62.64 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.33 -28.24 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.134 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -52.42 133.14 35.31 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.537 0.335 . . . . 0.0 110.72 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.01 83.42 0.72 Allowed Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.457 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.83 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.5 t -81.04 -39.06 26.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.877 0.37 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -127.02 71.94 75.99 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.695 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 10.1 Cg_exo -72.45 -52.0 0.19 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.793 2.329 . . . . 0.0 112.103 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -160.67 36.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.892 0.377 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.04 43.72 88.22 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.39 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 t -126.63 -35.93 2.29 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.823 -0.222 . . . . 0.0 110.613 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -167.7 128.95 1.48 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.175 0.512 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 8' ' ' CYS . . . 169.68 138.18 2.43 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -163.21 138.96 6.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.269 0.534 . . . . 0.0 111.137 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -140.31 140.58 35.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -51.03 -36.08 37.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.448 ' H ' HG12 ' A' ' 2' ' ' ILE . 25.5 p -68.27 -35.01 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.75 36.35 91.08 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 9.4 t80 -136.67 58.41 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.679 0.752 . . . . 0.0 109.601 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.6 m -82.38 136.0 35.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.012 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -114.57 134.75 54.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.863 0.363 . . . . 0.0 111.301 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 85.0 tttt -135.27 147.48 49.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.548 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 54.6 tt0 -145.67 145.1 24.4 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 25' ' ' GLN . 38.3 Cg_endo -66.37 48.03 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.283 2.656 . . . . 0.0 113.239 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.76 16.65 2.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.472 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.5 p90 -167.24 154.05 8.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.47 -56.79 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 128.11 8.3 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.425 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -80.53 152.82 28.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.215 0.531 . . . . 0.0 112.035 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.3 m -76.93 131.8 38.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.35 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 59.3 mtp180 -101.75 148.54 25.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.057 0.456 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' A' ' 2' ' ' ILE . 73.0 mtp180 -92.56 -38.77 11.73 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.504 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.38 0.133 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.868 HG13 ' SG ' ' A' ' 17' ' ' CYS . 29.2 mm -50.57 146.03 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 6' ' ' ASN . 24.6 ttmm -145.96 165.55 28.64 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.404 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 5.5 t-20 -67.75 67.43 0.1 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.043 0.838 . . . . 0.0 111.241 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.9 -20.28 0.21 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' A' ' 3' ' ' LYS . 62.1 m-20 -63.65 136.24 57.35 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.184 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.74 139.94 41.85 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.942 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 34.6 t -113.9 -42.82 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.349 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.577 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 30.5 mm-40 -154.36 77.19 5.47 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 12.5 Cg_exo -68.99 124.12 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.468 2.112 . . . . 0.0 111.042 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 69.38 -57.06 0.54 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.884 0.874 . . . . 0.0 111.338 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.19 -25.15 3.05 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 m -59.99 -39.19 84.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 111.904 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.459 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 23.5 tp60 -159.39 135.05 8.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 9' ' ' GLN . . . -170.71 138.97 5.24 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.211 -0.518 . . . . 0.0 112.01 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -141.06 141.69 34.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.868 ' SG ' HG13 ' A' ' 2' ' ' ILE . 1.7 t -149.73 127.08 11.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.06 -26.99 67.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.873 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.61 ' OG ' ' HG3' ' A' ' 35' ' ' ARG . 33.7 t -74.01 -40.07 63.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.659 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.62 47.12 12.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.539 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 28.9 t80 -144.91 70.77 1.28 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.9 m -68.62 80.09 0.28 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.803 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -70.63 94.63 1.02 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.823 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 61.1 tttm -141.85 44.98 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.344 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.595 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 74.2 mt-30 -68.65 -52.57 18.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.772 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 21.1 Cg_exo -66.78 157.93 58.77 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.174 1.916 . . . . 0.0 111.16 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.52 38.86 0.73 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 114.52 0.568 . . . . 0.0 114.52 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.823 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -81.41 151.03 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.639 0.719 . . . . 0.0 109.574 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.84 -46.45 91.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -108.14 119.4 39.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.26 139.96 17.18 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -122.46 157.43 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.928 0.864 . . . . 0.0 112.6 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 1.5 m -87.0 114.41 23.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -90.68 47.69 1.45 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.533 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.61 ' HG3' ' OG ' ' A' ' 19' ' ' SER . 13.5 ptm180 -177.19 -147.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.709 0.29 . . . . 0.0 110.72 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 tptm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.688 179.583 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.303 0.097 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.647 HG22 ' HB3' ' A' ' 6' ' ' ASN . 2.1 pp -45.34 129.4 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 O-C-N 123.732 0.645 . . . . 0.0 112.178 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -86.54 45.14 1.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 35' ' ' ARG . 81.1 m-20 53.4 38.37 27.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.094 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.36 33.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.429 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.647 ' HB3' HG22 ' A' ' 2' ' ' ILE . 26.2 t-20 -101.03 136.44 40.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.3 119.8 20.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.495 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.751 ' SG ' ' HG3' ' A' ' 14' ' ' GLN . 42.2 t -98.4 -53.36 3.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.529 0.204 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.0 101.34 16.62 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.128 0.49 . . . . 0.0 110.591 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 59.0 Cg_endo -72.82 -36.42 4.67 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.314 2.676 . . . . 0.0 112.71 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -158.41 56.68 0.45 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.039 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.61 40.17 54.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -145.8 80.23 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.751 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.2 tt0 -64.16 115.44 4.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.19 -67.24 1.76 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.582 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -177.12 149.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 0.0 110.343 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 2' ' ' ILE . 41.8 t -154.66 136.13 14.2 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.6 t -62.14 -45.94 91.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.141 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 p -89.86 -36.56 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.101 0.477 . . . . 0.0 110.919 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.69 19.31 60.09 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 29.3 t80 -96.8 56.94 1.51 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.642 0.734 . . . . 0.0 109.193 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.2 m -75.63 71.37 2.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.865 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 34' ' ' ARG . 6.6 p-80 -78.13 135.96 37.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.96 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.693 ' HB2' ' HE1' ' A' ' 28' ' ' TRP . 20.0 ptmt -164.26 148.43 9.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.16 0.505 . . . . 0.0 111.635 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -114.41 155.67 45.52 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.464 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.03 32.01 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.019 2.479 . . . . 0.0 113.705 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.99 -50.56 0.93 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.704 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.693 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 p90 -90.71 -176.07 4.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.632 0.253 . . . . 0.0 110.618 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.85 -79.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -92.93 134.63 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 24' ' ' LYS . . . -78.59 156.07 42.25 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -133.15 148.69 52.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.806 0.803 . . . . 0.0 111.76 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.605 ' HB2' HD13 ' A' ' 2' ' ' ILE . 57.1 m -73.49 138.62 45.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . 47.6 ttt180 -119.94 137.55 53.98 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 79.3 mtm180 -137.32 120.14 16.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.008 0.432 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.248 0.997 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.845 179.315 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.384 0.135 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.554 HG13 ' SG ' ' A' ' 18' ' ' CYS . 43.7 mt 64.52 48.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 122.188 0.994 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -141.1 135.91 31.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.637 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.705 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 19.7 p30 -66.74 138.06 57.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.29 46.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.101 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -66.67 130.51 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.75 134.53 44.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.345 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.3 p -132.59 -21.42 2.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.699 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.482 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 71.9 mm-40 -136.07 85.41 28.32 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 111.043 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 60.1 Cg_endo -74.26 76.22 3.14 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.867 2.378 . . . . 0.0 111.498 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.5 t30 75.3 -56.22 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.18 92.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 p -159.03 -58.51 0.07 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.63 0.252 . . . . 0.0 110.807 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -171.33 133.65 0.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.73 149.79 5.8 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -177.2 146.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 110.735 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.21 143.57 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.554 ' SG ' HG13 ' A' ' 2' ' ' ILE . 10.0 p -67.5 -52.83 34.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.916 0.326 . . . . 0.0 111.45 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.451 ' HB2' HD11 ' A' ' 2' ' ' ILE . 15.7 m -142.64 61.25 1.43 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -125.35 1.65 Allowed Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.03 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -160.33 117.97 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.584 0.231 . . . . 0.0 110.461 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 9' ' ' GLN . 48.8 t -82.98 145.64 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -143.71 120.73 11.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.243 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.659 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 50.8 tttp -157.88 125.54 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.593 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 88.3 mt-30 -121.34 -62.84 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 41.5 Cg_endo -85.24 -156.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.541 1.494 . . . . 0.0 110.327 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 -52.1 4.12 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.853 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 27.07 50.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.419 1.488 . . . . 0.0 114.51 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.4 t 70.75 -57.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.344 0.657 . . . . 0.0 111.849 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.73 146.6 2.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.611 0.243 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -63.92 140.59 44.09 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -123.78 148.68 46.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 112.241 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 85.8 m -70.37 132.15 45.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -98.21 22.84 8.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 72.01 -51.1 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.265 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.724 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.527 0.203 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.475 HD11 ' C ' ' A' ' 19' ' ' SER . 78.6 mt 70.16 120.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.943 0.777 . . . . 0.0 112.787 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -152.09 121.17 6.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 81.1 m-20 -77.06 60.25 1.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.393 0.616 . . . . 0.0 111.07 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.18 -40.48 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.707 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -63.83 134.74 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . -70.2 110.05 3.14 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.343 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 p -84.94 -38.27 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 0.0 109.594 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -123.71 77.37 56.43 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.713 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.533 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 3.9 Cg_exo -78.26 -44.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.526 2.818 . . . . 0.0 114.103 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.49 55.36 0.44 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.76 38.79 41.54 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.71 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.533 ' OG ' ' HD2' ' A' ' 10' ' ' PRO . 25.6 p -100.0 37.23 1.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 122.46 -0.435 . . . . 0.0 110.008 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 69.85 -59.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.164 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.77 -142.0 9.05 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.75 -138.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.51 64.06 1.94 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.4 m -38.28 -38.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.475 ' C ' HD11 ' A' ' 2' ' ' ILE . 9.1 t -138.34 45.77 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 110.031 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.41 -139.17 3.21 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.547 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.514 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 25.2 t80 -143.88 122.53 12.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.884 0.374 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 51.6 t -86.34 118.04 25.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -103.2 124.06 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.128 0.49 . . . . 0.0 111.196 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 9' ' ' GLN . 61.8 tttm -142.54 137.87 30.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -155.86 154.05 27.07 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.65 117.51 3.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.923 2.415 . . . . 0.0 112.527 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.54 -60.24 0.4 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.302 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.402 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.3 p90 -93.23 159.43 15.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.94 -49.69 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.793 0.33 . . . . 0.0 111.808 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -115.28 132.45 56.61 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . -75.17 150.34 40.5 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -127.41 155.66 43.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 118.003 0.901 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 64.8 m -64.02 133.32 52.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -123.82 51.14 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 64.78 -98.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.5 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 21' ' ' TYR . 26.8 tptp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.196 -0.906 . . . . 0.0 109.717 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.845 HG22 ' HD3' ' A' ' 35' ' ' ARG . 28.7 mt 67.71 72.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.093 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HE3' ' OD1' ' A' ' 6' ' ' ASN . 52.8 pttt -155.43 145.8 21.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -60.59 146.03 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.34 -38.78 3.06 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.989 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.401 ' OD1' ' HE3' ' A' ' 3' ' ' LYS . 3.3 m120 -69.09 136.48 52.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.68 0.276 . . . . 0.0 110.9 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.52 85.91 0.62 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 t -54.28 -44.29 71.77 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.224 0.61 . . . . 0.0 111.675 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 38.3 tt0 -145.52 87.89 6.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.658 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.38 -43.1 2.31 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.825 2.35 . . . . 0.0 111.739 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -159.69 40.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.52 42.21 99.72 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.597 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -64.43 -52.25 59.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.583 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -60.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.55 103.48 0.19 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.901 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.1 -50.3 64.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.265 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -86.66 144.94 26.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.57 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.451 ' HB2' HD11 ' A' ' 2' ' ' ILE . 14.6 m -73.3 71.75 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.874 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.7 m 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 109.715 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 18.12 54.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.955 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.2 t80 58.9 92.72 0.04 OUTLIER 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.07 0.938 . . . . 0.0 110.618 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.8 134.16 39.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.733 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.1 118.45 24.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.627 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 25.4 ttpp -136.59 124.82 23.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.622 0.725 . . . . 0.0 112.48 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.9 139.27 24.59 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.67 52.53 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.773 2.316 . . . . 0.0 113.339 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.5 39.58 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.128 -1.035 . . . . 0.0 114.183 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.627 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.5 OUTLIER -151.31 28.8 0.65 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.081 0.94 . . . . 0.0 112.429 178.036 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.4 t 67.8 -53.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.14 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.04 133.81 12.11 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.354 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -86.78 155.7 20.21 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.464 0.306 . . . . 0.0 110.802 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.35 122.18 23.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -83.14 66.21 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.071 0.462 . . . . 0.0 111.773 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.845 ' HD3' HG22 ' A' ' 2' ' ' ILE . 11.8 tpt180 -76.52 61.7 1.79 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.788 0.804 . . . . 0.0 109.6 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.142 -0.933 . . . . 0.0 109.831 -179.338 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.776 HG13 ' HG2' ' A' ' 35' ' ' ARG . 5.2 tp -83.34 112.11 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.319 0.58 . . . . 0.0 110.259 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -166.56 137.41 3.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.069 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 18.8 p30 -69.65 133.97 48.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -31.17 8.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.282 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.09 140.22 57.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.723 0.297 . . . . 0.0 110.337 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 95.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.525 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 11.9 t -83.25 -46.62 12.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.179 0.514 . . . . 0.0 109.636 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 83.2 mt-30 -140.57 79.38 20.16 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.225 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 30' ' ' ALA . 7.2 Cg_exo -74.31 51.48 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 113.518 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 t30 58.81 71.06 0.61 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 111.611 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.1 55.27 5.3 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.5 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 58.4 m -149.96 148.09 28.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.42 135.39 56.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 0.0 111.735 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.47 126.85 1.1 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -142.98 127.23 17.6 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 m -78.97 131.75 36.44 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB2' HG22 ' A' ' 2' ' ' ILE . 89.8 m -53.84 -46.52 71.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.9 p -72.68 -47.54 46.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.037 0.446 . . . . 0.0 110.33 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.9 2.14 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.489 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -66.16 126.99 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.369 0.604 . . . . 0.0 112.463 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.92 145.51 49.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.546 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -124.43 117.8 25.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.761 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 65.7 tttm -155.21 114.68 3.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.553 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 68.0 mt-30 -147.39 -51.98 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.503 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 24.5 Cg_exo -63.23 159.28 40.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.836 1.691 . . . . 0.0 111.442 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.57 45.47 2.4 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.762 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.761 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -78.74 167.39 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 111.068 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.5 -28.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.411 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -157.58 136.22 11.36 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 147.1 30.5 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -127.02 159.01 35.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.888 0.844 . . . . 0.0 112.867 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 58.0 m -78.67 178.76 7.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.281 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -159.83 133.62 7.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.776 ' HG2' HG13 ' A' ' 2' ' ' ILE . 75.7 mtp180 -84.72 -154.38 0.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.808 0.337 . . . . 0.0 110.566 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.134 179.348 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.3 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 74.9 mt 70.6 158.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 123.403 0.439 . . . . 0.0 111.787 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 9.1 mtpm? 78.47 149.03 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.853 0.861 . . . . 0.0 112.292 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 77.9 m-20 -71.76 56.72 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.388 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.55 0.12 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -161.86 145.9 12.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.12 137.02 50.68 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 123.568 0.542 . . . . 0.0 113.084 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 9' ' ' GLN . 9.3 t -140.88 -50.72 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.503 0.192 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.735 ' HG2' ' HA3' ' A' ' 15' ' ' GLY . 78.7 mt-30 -135.0 70.49 70.2 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.453 0.168 . . . . 0.0 111.18 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 18.1 Cg_endo -61.5 -39.25 56.89 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.072 2.515 . . . . 0.0 113.418 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -147.12 24.47 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.28 0.562 . . . . 0.0 111.387 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.1 30.96 77.93 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.547 -0.751 . . . . 0.0 114.908 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -83.2 58.81 4.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.603 0.702 . . . . 0.0 109.807 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 62.81 49.18 3.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.373 0.606 . . . . 0.0 109.397 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.735 ' HA3' ' HG2' ' A' ' 9' ' ' GLN . . . -60.75 134.09 49.6 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.776 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -157.77 127.75 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.872 0.368 . . . . 0.0 110.301 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.4 t -95.5 148.24 22.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.195 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.07 -34.92 66.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.223 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' HG12 ' A' ' 2' ' ' ILE . 12.0 p -63.78 -29.0 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.73 30.85 14.01 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 2.7 t80 -159.93 133.15 6.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.1 t -133.1 -171.76 2.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.963 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -164.56 118.58 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.845 0.355 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.632 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 86.1 tttt -147.38 119.21 8.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.455 0.645 . . . . 0.0 110.72 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -94.8 149.75 36.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.276 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.73 57.45 1.47 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.016 2.478 . . . . 0.0 112.519 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.43 -59.72 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.26 -0.495 . . . . 0.0 111.949 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.632 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -72.59 156.4 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 t -73.74 -63.75 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.906 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -93.37 124.91 37.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.54 136.03 14.22 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.63 165.09 12.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.983 0.421 . . . . 0.0 111.953 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 98.0 m -70.61 169.91 13.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.847 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 26.4 ttp180 -151.36 142.22 22.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.684 ' HG3' ' HG2' ' A' ' 36' ' ' LYS . 38.8 ptt180 -99.3 -34.19 10.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.118 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.684 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 21.3 pttp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.138 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CG1' ' HB2' ' A' ' 18' ' ' CYS . 54.8 mt 74.66 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.433 0.458 . . . . 0.0 110.338 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HG3' HG22 ' A' ' 2' ' ' ILE . 30.1 mtpp 74.94 148.53 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.184 0.594 . . . . 0.0 110.434 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 66.2 m-80 -59.64 137.93 57.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.324 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 32' ' ' TYR . . . 135.09 -46.91 1.01 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.582 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 10.1 t-20 -63.33 126.43 27.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.903 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.99 76.94 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.544 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 21.7 p -69.3 -44.34 71.99 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.587 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 4.2 tp60 -129.08 82.28 68.9 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.57 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 38.1 Cg_exo -57.86 -42.33 60.0 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.494 2.129 . . . . 0.0 110.971 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -162.64 -31.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.823 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.59 55.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.908 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 p -95.42 -58.22 2.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.591 0.195 . . . . 0.0 110.614 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 176.59 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 123.614 0.571 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 8' ' ' CYS . . . 81.03 53.5 3.91 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -76.03 54.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.0 m -70.73 134.73 47.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . 55.6 m -69.75 -22.69 63.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.4 p -173.77 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 111.329 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -50.59 -20.87 4.22 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.05 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 20' ' ' GLY . 4.0 t80 72.81 115.08 0.06 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.528 0.68 . . . . 0.0 110.429 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 31.8 t -67.96 135.51 52.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.125 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -142.54 129.37 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.56 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.656 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 27.2 ttpp -140.02 120.97 14.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.684 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -85.6 144.77 40.56 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 56.3 1.87 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.622 2.215 . . . . 0.0 113.205 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.53 34.28 0.12 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.118 -1.039 . . . . 0.0 114.23 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.625 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -158.75 12.12 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.998 0.899 . . . . 0.0 112.089 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m 31.26 44.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -179.09 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.128 0.489 . . . . 0.0 111.138 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -86.62 151.26 24.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.656 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -135.82 159.69 40.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 111.413 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 62.3 m -66.73 129.18 39.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.294 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.7 -144.35 0.08 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -141.42 138.72 33.13 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.531 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 49.8 t . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.564 HG12 ' HA2' ' A' ' 20' ' ' GLY . 26.7 mt -65.57 119.51 10.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -153.55 24.68 0.52 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 59.08 121.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.797 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.816 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 65.04 23.01 69.28 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.622 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 6.1 t-20 -84.68 162.87 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.34 88.37 0.1 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.192 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.82 -33.67 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 55.8 tt0 -154.79 64.55 4.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.629 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 14' ' ' GLN . 73.0 Cg_endo -77.57 -44.83 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.759 2.306 . . . . 0.0 112.832 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.26 -32.78 38.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.617 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.62 -35.93 3.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.597 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -68.29 -50.52 53.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 109.881 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 18.9 tt0 -169.46 -142.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.03 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.11 -139.79 2.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.705 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -137.42 42.06 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 111.793 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 m -122.68 117.93 26.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.9 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -48.95 78.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.667 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -153.71 45.93 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA2' HG12 ' A' ' 2' ' ' ILE . . . -73.64 -7.81 75.15 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.283 -1.326 . . . . 0.0 114.136 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 14.5 t80 67.31 74.08 0.32 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.0 109.331 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.81 124.41 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.281 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -120.47 120.14 35.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 57.2 tttm -147.3 127.65 13.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.281 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -141.46 155.85 67.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.487 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.5 113.65 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.662 2.241 . . . . 0.0 111.58 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.01 -47.13 0.52 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.538 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 2.0 p90 -110.78 151.17 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.94 -38.28 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.01 127.63 54.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.7 134.11 14.71 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.816 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 20.0 p90 -104.66 152.23 22.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 20' ' ' GLY . 3.9 m -81.8 118.11 22.63 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.601 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 79.2 ttt180 -107.45 132.92 52.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.56 109.55 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.853 -179.033 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.673 HG22 ' HG2' ' A' ' 35' ' ' ARG . 27.1 mt 66.72 47.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 122.041 0.924 . . . . 0.0 109.899 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -88.89 131.37 35.15 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.427 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -72.64 62.64 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.33 -28.24 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.134 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -52.42 133.14 35.31 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.537 0.335 . . . . 0.0 110.72 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.01 83.42 0.72 Allowed Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.457 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.83 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.5 t -81.04 -39.06 26.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.877 0.37 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -127.02 71.94 75.99 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.695 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 10.1 Cg_exo -72.45 -52.0 0.19 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.793 2.329 . . . . 0.0 112.103 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -160.67 36.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.892 0.377 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.04 43.72 88.22 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.39 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 t -126.63 -35.93 2.29 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.823 -0.222 . . . . 0.0 110.613 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -167.7 128.95 1.48 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.175 0.512 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 8' ' ' CYS . . . 169.68 138.18 2.43 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -163.21 138.96 6.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.269 0.534 . . . . 0.0 111.137 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -140.31 140.58 35.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -51.03 -36.08 37.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.448 ' H ' HG12 ' A' ' 2' ' ' ILE . 25.5 p -68.27 -35.01 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.75 36.35 91.08 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 9.4 t80 -136.67 58.41 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.679 0.752 . . . . 0.0 109.601 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.6 m -82.38 136.0 35.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.012 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -114.57 134.75 54.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.863 0.363 . . . . 0.0 111.301 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 85.0 tttt -135.27 147.48 49.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.548 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 54.6 tt0 -145.67 145.1 24.4 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 25' ' ' GLN . 38.3 Cg_endo -66.37 48.03 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.283 2.656 . . . . 0.0 113.239 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.76 16.65 2.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.472 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.5 p90 -167.24 154.05 8.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.47 -56.79 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 128.11 8.3 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.425 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -80.53 152.82 28.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.215 0.531 . . . . 0.0 112.035 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.3 m -76.93 131.8 38.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.35 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 59.3 mtp180 -101.75 148.54 25.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.057 0.456 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' A' ' 2' ' ' ILE . 73.0 mtp180 -92.56 -38.77 11.73 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.504 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.38 0.133 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.868 HG13 ' SG ' ' A' ' 17' ' ' CYS . 29.2 mm -50.57 146.03 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 6' ' ' ASN . 24.6 ttmm -145.96 165.55 28.64 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.404 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 5.5 t-20 -67.75 67.43 0.1 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.043 0.838 . . . . 0.0 111.241 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.9 -20.28 0.21 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' A' ' 3' ' ' LYS . 62.1 m-20 -63.65 136.24 57.35 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.184 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.74 139.94 41.85 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.942 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 34.6 t -113.9 -42.82 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.349 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.577 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 30.5 mm-40 -154.36 77.19 5.47 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 12.5 Cg_exo -68.99 124.12 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.468 2.112 . . . . 0.0 111.042 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 69.38 -57.06 0.54 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.884 0.874 . . . . 0.0 111.338 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.19 -25.15 3.05 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 m -59.99 -39.19 84.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 111.904 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.459 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 23.5 tp60 -159.39 135.05 8.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 9' ' ' GLN . . . -170.71 138.97 5.24 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.211 -0.518 . . . . 0.0 112.01 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -141.06 141.69 34.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.868 ' SG ' HG13 ' A' ' 2' ' ' ILE . 1.7 t -149.73 127.08 11.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.06 -26.99 67.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.873 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.61 ' OG ' ' HG3' ' A' ' 35' ' ' ARG . 33.7 t -74.01 -40.07 63.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.659 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.62 47.12 12.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.539 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 28.9 t80 -144.91 70.77 1.28 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.9 m -68.62 80.09 0.28 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.803 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -70.63 94.63 1.02 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.823 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 61.1 tttm -141.85 44.98 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.344 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.595 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 74.2 mt-30 -68.65 -52.57 18.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.772 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 21.1 Cg_exo -66.78 157.93 58.77 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.174 1.916 . . . . 0.0 111.16 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.52 38.86 0.73 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 114.52 0.568 . . . . 0.0 114.52 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.823 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -81.41 151.03 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.639 0.719 . . . . 0.0 109.574 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.84 -46.45 91.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -108.14 119.4 39.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.26 139.96 17.18 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -122.46 157.43 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.928 0.864 . . . . 0.0 112.6 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 1.5 m -87.0 114.41 23.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -90.68 47.69 1.45 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.533 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.61 ' HG3' ' OG ' ' A' ' 19' ' ' SER . 13.5 ptm180 -177.19 -147.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.709 0.29 . . . . 0.0 110.72 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 tptm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.688 179.583 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.303 0.097 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.647 HG22 ' HB3' ' A' ' 6' ' ' ASN . 2.1 pp -45.34 129.4 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 O-C-N 123.732 0.645 . . . . 0.0 112.178 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -86.54 45.14 1.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 35' ' ' ARG . 81.1 m-20 53.4 38.37 27.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.094 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.36 33.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.429 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.647 ' HB3' HG22 ' A' ' 2' ' ' ILE . 26.2 t-20 -101.03 136.44 40.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.3 119.8 20.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.495 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.751 ' SG ' ' HG3' ' A' ' 14' ' ' GLN . 42.2 t -98.4 -53.36 3.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.529 0.204 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.0 101.34 16.62 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.128 0.49 . . . . 0.0 110.591 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 59.0 Cg_endo -72.82 -36.42 4.67 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.314 2.676 . . . . 0.0 112.71 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -158.41 56.68 0.45 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.039 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.61 40.17 54.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -145.8 80.23 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.751 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.2 tt0 -64.16 115.44 4.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.19 -67.24 1.76 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.582 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -177.12 149.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 0.0 110.343 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 2' ' ' ILE . 41.8 t -154.66 136.13 14.2 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.6 t -62.14 -45.94 91.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.141 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 p -89.86 -36.56 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.101 0.477 . . . . 0.0 110.919 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.69 19.31 60.09 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 29.3 t80 -96.8 56.94 1.51 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.642 0.734 . . . . 0.0 109.193 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.2 m -75.63 71.37 2.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.865 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 34' ' ' ARG . 6.6 p-80 -78.13 135.96 37.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.96 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.693 ' HB2' ' HE1' ' A' ' 28' ' ' TRP . 20.0 ptmt -164.26 148.43 9.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.16 0.505 . . . . 0.0 111.635 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -114.41 155.67 45.52 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.464 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.03 32.01 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.019 2.479 . . . . 0.0 113.705 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.99 -50.56 0.93 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.704 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.693 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 p90 -90.71 -176.07 4.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.632 0.253 . . . . 0.0 110.618 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.85 -79.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -92.93 134.63 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 24' ' ' LYS . . . -78.59 156.07 42.25 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -133.15 148.69 52.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.806 0.803 . . . . 0.0 111.76 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.605 ' HB2' HD13 ' A' ' 2' ' ' ILE . 57.1 m -73.49 138.62 45.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . 47.6 ttt180 -119.94 137.55 53.98 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 79.3 mtm180 -137.32 120.14 16.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.008 0.432 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.248 0.997 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.845 179.315 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.384 0.135 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.554 HG13 ' SG ' ' A' ' 18' ' ' CYS . 43.7 mt 64.52 48.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 122.188 0.994 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -141.1 135.91 31.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.637 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.705 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 19.7 p30 -66.74 138.06 57.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.29 46.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.101 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -66.67 130.51 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.75 134.53 44.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.345 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.3 p -132.59 -21.42 2.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.699 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.482 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 71.9 mm-40 -136.07 85.41 28.32 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 111.043 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 60.1 Cg_endo -74.26 76.22 3.14 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.867 2.378 . . . . 0.0 111.498 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.5 t30 75.3 -56.22 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.18 92.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 p -159.03 -58.51 0.07 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.63 0.252 . . . . 0.0 110.807 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -171.33 133.65 0.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.73 149.79 5.8 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -177.2 146.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 110.735 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.21 143.57 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.554 ' SG ' HG13 ' A' ' 2' ' ' ILE . 10.0 p -67.5 -52.83 34.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.916 0.326 . . . . 0.0 111.45 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.451 ' HB2' HD11 ' A' ' 2' ' ' ILE . 15.7 m -142.64 61.25 1.43 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -125.35 1.65 Allowed Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.03 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -160.33 117.97 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.584 0.231 . . . . 0.0 110.461 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 9' ' ' GLN . 48.8 t -82.98 145.64 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -143.71 120.73 11.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.243 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.659 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 50.8 tttp -157.88 125.54 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.593 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 88.3 mt-30 -121.34 -62.84 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 41.5 Cg_endo -85.24 -156.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.541 1.494 . . . . 0.0 110.327 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 -52.1 4.12 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.853 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 27.07 50.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.419 1.488 . . . . 0.0 114.51 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.4 t 70.75 -57.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.344 0.657 . . . . 0.0 111.849 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.73 146.6 2.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.611 0.243 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -63.92 140.59 44.09 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -123.78 148.68 46.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 112.241 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 85.8 m -70.37 132.15 45.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -98.21 22.84 8.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 72.01 -51.1 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.265 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.724 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.527 0.203 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.475 HD11 ' C ' ' A' ' 19' ' ' SER . 78.6 mt 70.16 120.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.943 0.777 . . . . 0.0 112.787 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -152.09 121.17 6.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 81.1 m-20 -77.06 60.25 1.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.393 0.616 . . . . 0.0 111.07 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.18 -40.48 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.707 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -63.83 134.74 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . -70.2 110.05 3.14 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.343 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 p -84.94 -38.27 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 0.0 109.594 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -123.71 77.37 56.43 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.713 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.533 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 3.9 Cg_exo -78.26 -44.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.526 2.818 . . . . 0.0 114.103 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.49 55.36 0.44 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.76 38.79 41.54 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.71 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.533 ' OG ' ' HD2' ' A' ' 10' ' ' PRO . 25.6 p -100.0 37.23 1.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 122.46 -0.435 . . . . 0.0 110.008 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 69.85 -59.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.164 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.77 -142.0 9.05 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.75 -138.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.51 64.06 1.94 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.4 m -38.28 -38.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.475 ' C ' HD11 ' A' ' 2' ' ' ILE . 9.1 t -138.34 45.77 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 110.031 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.41 -139.17 3.21 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.547 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.514 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 25.2 t80 -143.88 122.53 12.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.884 0.374 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 51.6 t -86.34 118.04 25.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -103.2 124.06 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.128 0.49 . . . . 0.0 111.196 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 9' ' ' GLN . 61.8 tttm -142.54 137.87 30.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -155.86 154.05 27.07 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.65 117.51 3.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.923 2.415 . . . . 0.0 112.527 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.54 -60.24 0.4 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.302 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.402 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.3 p90 -93.23 159.43 15.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.94 -49.69 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.793 0.33 . . . . 0.0 111.808 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -115.28 132.45 56.61 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . -75.17 150.34 40.5 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -127.41 155.66 43.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 118.003 0.901 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 64.8 m -64.02 133.32 52.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -123.82 51.14 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 64.78 -98.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.5 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 21' ' ' TYR . 26.8 tptp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.196 -0.906 . . . . 0.0 109.717 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.845 HG22 ' HD3' ' A' ' 35' ' ' ARG . 28.7 mt 67.71 72.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.093 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HE3' ' OD1' ' A' ' 6' ' ' ASN . 52.8 pttt -155.43 145.8 21.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -60.59 146.03 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.34 -38.78 3.06 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.989 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' OD1' ' HE3' ' A' ' 3' ' ' LYS . 3.3 m120 -69.09 136.48 52.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.68 0.276 . . . . 0.0 110.9 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.52 85.91 0.62 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 t -54.28 -44.29 71.77 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.224 0.61 . . . . 0.0 111.675 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 38.3 tt0 -145.52 87.89 6.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.658 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.38 -43.1 2.31 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.825 2.35 . . . . 0.0 111.739 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -159.69 40.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.52 42.21 99.72 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.597 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -64.43 -52.25 59.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.583 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -60.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.55 103.48 0.19 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.901 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.1 -50.3 64.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.265 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -86.66 144.94 26.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.57 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.451 ' HB2' HD11 ' A' ' 2' ' ' ILE . 14.6 m -73.3 71.75 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.874 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.7 m 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 109.715 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 18.12 54.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.955 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.2 t80 58.9 92.72 0.04 OUTLIER 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.07 0.938 . . . . 0.0 110.618 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.8 134.16 39.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.733 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.1 118.45 24.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.627 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 25.4 ttpp -136.59 124.82 23.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.622 0.725 . . . . 0.0 112.48 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.9 139.27 24.59 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.67 52.53 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.773 2.316 . . . . 0.0 113.339 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.5 39.58 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.128 -1.035 . . . . 0.0 114.183 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.627 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.5 OUTLIER -151.31 28.8 0.65 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.081 0.94 . . . . 0.0 112.429 178.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.4 t 67.8 -53.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.14 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.04 133.81 12.11 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.354 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -86.78 155.7 20.21 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.464 0.306 . . . . 0.0 110.802 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.35 122.18 23.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -83.14 66.21 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.071 0.462 . . . . 0.0 111.773 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.845 ' HD3' HG22 ' A' ' 2' ' ' ILE . 11.8 tpt180 -76.52 61.7 1.79 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.788 0.804 . . . . 0.0 109.6 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.142 -0.933 . . . . 0.0 109.831 -179.338 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.776 HG13 ' HG2' ' A' ' 35' ' ' ARG . 5.2 tp -83.34 112.11 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.319 0.58 . . . . 0.0 110.259 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -166.56 137.41 3.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.069 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 18.8 p30 -69.65 133.97 48.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -31.17 8.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.282 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.09 140.22 57.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.723 0.297 . . . . 0.0 110.337 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 95.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.525 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 11.9 t -83.25 -46.62 12.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.179 0.514 . . . . 0.0 109.636 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 83.2 mt-30 -140.57 79.38 20.16 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.225 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 30' ' ' ALA . 7.2 Cg_exo -74.31 51.48 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 113.518 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 t30 58.81 71.06 0.61 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 111.611 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.1 55.27 5.3 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.5 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 58.4 m -149.96 148.09 28.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -57.42 135.39 56.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 0.0 111.735 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.47 126.85 1.1 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -142.98 127.23 17.6 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 m -78.97 131.75 36.44 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB2' HG22 ' A' ' 2' ' ' ILE . 89.8 m -53.84 -46.52 71.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.9 p -72.68 -47.54 46.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.037 0.446 . . . . 0.0 110.33 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.9 2.14 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.489 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -66.16 126.99 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.369 0.604 . . . . 0.0 112.463 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.92 145.51 49.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.546 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -124.43 117.8 25.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.761 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 65.7 tttm -155.21 114.68 3.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.553 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 68.0 mt-30 -147.39 -51.98 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.503 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 24.5 Cg_exo -63.23 159.28 40.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.836 1.691 . . . . 0.0 111.442 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.57 45.47 2.4 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.762 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.761 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -78.74 167.39 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 111.068 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.5 -28.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.411 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -157.58 136.22 11.36 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 147.1 30.5 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -127.02 159.01 35.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.888 0.844 . . . . 0.0 112.867 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 58.0 m -78.67 178.76 7.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.281 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -159.83 133.62 7.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.776 ' HG2' HG13 ' A' ' 2' ' ' ILE . 75.7 mtp180 -84.72 -154.38 0.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.808 0.337 . . . . 0.0 110.566 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.134 179.348 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.3 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 74.9 mt 70.6 158.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 123.403 0.439 . . . . 0.0 111.787 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 9.1 mtpm? 78.47 149.03 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.853 0.861 . . . . 0.0 112.292 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 77.9 m-20 -71.76 56.72 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.388 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.55 0.12 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -161.86 145.9 12.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.12 137.02 50.68 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 123.568 0.542 . . . . 0.0 113.084 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 9' ' ' GLN . 9.3 t -140.88 -50.72 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.503 0.192 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.735 ' HG2' ' HA3' ' A' ' 15' ' ' GLY . 22.7 mt-30 -135.0 70.49 70.2 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.453 0.168 . . . . 0.0 111.18 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 18.1 Cg_endo -61.5 -39.25 56.89 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.072 2.515 . . . . 0.0 113.418 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -147.12 24.47 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.28 0.562 . . . . 0.0 111.387 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.1 30.96 77.93 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.547 -0.751 . . . . 0.0 114.908 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -83.2 58.81 4.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.603 0.702 . . . . 0.0 109.807 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 62.81 49.18 3.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.373 0.606 . . . . 0.0 109.397 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.735 ' HA3' ' HG2' ' A' ' 9' ' ' GLN . . . -60.75 134.09 49.6 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.776 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -157.77 127.75 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.872 0.368 . . . . 0.0 110.301 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.4 t -95.5 148.24 22.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.195 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.07 -34.92 66.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.223 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' HG12 ' A' ' 2' ' ' ILE . 12.0 p -63.78 -29.0 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.73 30.85 14.01 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 2.7 t80 -159.93 133.15 6.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.1 t -133.1 -171.76 2.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.963 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -164.56 118.58 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.845 0.355 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.632 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 86.1 tttt -147.38 119.21 8.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.455 0.645 . . . . 0.0 110.72 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -94.8 149.75 36.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.276 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.73 57.45 1.47 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.016 2.478 . . . . 0.0 112.519 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.43 -59.72 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.26 -0.495 . . . . 0.0 111.949 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.632 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -72.59 156.4 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 t -73.74 -63.75 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.906 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -93.37 124.91 37.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.54 136.03 14.22 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.63 165.09 12.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.983 0.421 . . . . 0.0 111.953 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 98.0 m -70.61 169.91 13.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.847 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 26.4 ttp180 -151.36 142.22 22.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.684 ' HG3' ' HG2' ' A' ' 36' ' ' LYS . 38.8 ptt180 -99.3 -34.19 10.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.118 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.684 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 21.3 pttp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.138 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CG1' ' HB2' ' A' ' 18' ' ' CYS . 54.8 mt 74.66 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.433 0.458 . . . . 0.0 110.338 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HG3' HG22 ' A' ' 2' ' ' ILE . 30.1 mtpp 74.94 148.53 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.184 0.594 . . . . 0.0 110.434 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 66.2 m-80 -59.64 137.93 57.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.324 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 32' ' ' TYR . . . 135.09 -46.91 1.01 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.582 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 10.1 t-20 -63.33 126.43 27.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.903 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.99 76.94 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.544 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 21.7 p -69.3 -44.34 71.99 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.587 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 4.2 tp60 -129.08 82.28 68.9 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.57 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 38.1 Cg_exo -57.86 -42.33 60.0 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.494 2.129 . . . . 0.0 110.971 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -162.64 -31.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.823 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.59 55.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.908 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 p -95.42 -58.22 2.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.591 0.195 . . . . 0.0 110.614 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 176.59 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 123.614 0.571 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 8' ' ' CYS . . . 81.03 53.5 3.91 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -76.03 54.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.0 m -70.73 134.73 47.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . 55.6 m -69.75 -22.69 63.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.4 p -173.77 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 111.329 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -50.59 -20.87 4.22 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.05 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 20' ' ' GLY . 4.0 t80 72.81 115.08 0.06 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.528 0.68 . . . . 0.0 110.429 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 31.8 t -67.96 135.51 52.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.125 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -142.54 129.37 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.56 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.656 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 27.2 ttpp -140.02 120.97 14.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.684 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -85.6 144.77 40.56 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 56.3 1.87 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.622 2.215 . . . . 0.0 113.205 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.53 34.28 0.12 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.118 -1.039 . . . . 0.0 114.23 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.625 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -158.75 12.12 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.998 0.899 . . . . 0.0 112.089 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m 31.26 44.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -179.09 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.128 0.489 . . . . 0.0 111.138 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -86.62 151.26 24.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.656 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -135.82 159.69 40.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 111.413 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 62.3 m -66.73 129.18 39.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.294 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.7 -144.35 0.08 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -141.42 138.72 33.13 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.531 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 49.8 t . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.564 HG12 ' HA2' ' A' ' 20' ' ' GLY . 26.7 mt -65.57 119.51 10.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -153.55 24.68 0.52 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 59.08 121.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.797 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.816 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 65.04 23.01 69.28 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.622 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 6.1 t-20 -84.68 162.87 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.34 88.37 0.1 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.192 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.82 -33.67 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.3 tt0 -154.79 64.55 4.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.629 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 14' ' ' GLN . 73.0 Cg_endo -77.57 -44.83 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.759 2.306 . . . . 0.0 112.832 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.26 -32.78 38.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.617 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.62 -35.93 3.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.597 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -68.29 -50.52 53.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 109.881 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 18.9 tt0 -169.46 -142.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.03 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.11 -139.79 2.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.705 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -137.42 42.06 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 111.793 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 m -122.68 117.93 26.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.9 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -48.95 78.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.667 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -153.71 45.93 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA2' HG12 ' A' ' 2' ' ' ILE . . . -73.64 -7.81 75.15 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.283 -1.326 . . . . 0.0 114.136 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 14.5 t80 67.31 74.08 0.32 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.0 109.331 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.81 124.41 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.281 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -120.47 120.14 35.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 57.2 tttm -147.3 127.65 13.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.281 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -141.46 155.85 67.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.487 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.5 113.65 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.662 2.241 . . . . 0.0 111.58 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.01 -47.13 0.52 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.538 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 2.0 p90 -110.78 151.17 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.94 -38.28 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.01 127.63 54.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.7 134.11 14.71 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.816 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 20.0 p90 -104.66 152.23 22.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 20' ' ' GLY . 3.9 m -81.8 118.11 22.63 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.601 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 79.2 ttt180 -107.45 132.92 52.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.56 109.55 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.853 -179.033 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.673 HG22 ' HG2' ' A' ' 35' ' ' ARG . 27.1 mt 66.72 47.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 122.041 0.924 . . . . 0.0 109.899 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -88.89 131.37 35.15 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.427 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.64 62.64 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.33 -28.24 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.134 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -52.42 133.14 35.31 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.537 0.335 . . . . 0.0 110.72 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.01 83.42 0.72 Allowed Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.457 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.83 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.5 t -81.04 -39.06 26.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.877 0.37 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -127.02 71.94 75.99 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.695 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 10.1 Cg_exo -72.45 -52.0 0.19 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.793 2.329 . . . . 0.0 112.103 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -160.67 36.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.892 0.377 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.04 43.72 88.22 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.39 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 t -126.63 -35.93 2.29 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.823 -0.222 . . . . 0.0 110.613 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -167.7 128.95 1.48 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.175 0.512 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 8' ' ' CYS . . . 169.68 138.18 2.43 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -163.21 138.96 6.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.269 0.534 . . . . 0.0 111.137 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -140.31 140.58 35.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -51.03 -36.08 37.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.448 ' H ' HG12 ' A' ' 2' ' ' ILE . 25.5 p -68.27 -35.01 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.75 36.35 91.08 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 9.4 t80 -136.67 58.41 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.679 0.752 . . . . 0.0 109.601 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.6 m -82.38 136.0 35.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.012 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -114.57 134.75 54.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.863 0.363 . . . . 0.0 111.301 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 85.0 tttt -135.27 147.48 49.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.548 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 6.7 tt0 -145.67 145.1 24.4 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 25' ' ' GLN . 38.3 Cg_endo -66.37 48.03 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.283 2.656 . . . . 0.0 113.239 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.76 16.65 2.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.472 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.5 p90 -167.24 154.05 8.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.47 -56.79 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 128.11 8.3 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.425 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -80.53 152.82 28.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.215 0.531 . . . . 0.0 112.035 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.3 m -76.93 131.8 38.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.35 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 59.3 mtp180 -101.75 148.54 25.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.057 0.456 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' A' ' 2' ' ' ILE . 73.0 mtp180 -92.56 -38.77 11.73 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.504 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.38 0.133 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.868 HG13 ' SG ' ' A' ' 17' ' ' CYS . 29.2 mm -50.57 146.03 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 6' ' ' ASN . 24.6 ttmm -145.96 165.55 28.64 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.404 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 5.5 t-20 -67.75 67.43 0.1 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.043 0.838 . . . . 0.0 111.241 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.9 -20.28 0.21 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' A' ' 3' ' ' LYS . 3.6 m120 -63.65 136.24 57.35 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.184 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.74 139.94 41.85 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.942 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 34.6 t -113.9 -42.82 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.349 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.577 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 2.3 mm100 -154.36 77.19 5.47 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 12.5 Cg_exo -68.99 124.12 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.468 2.112 . . . . 0.0 111.042 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 69.38 -57.06 0.54 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.884 0.874 . . . . 0.0 111.338 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.19 -25.15 3.05 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 m -59.99 -39.19 84.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 111.904 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.459 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 23.5 tp60 -159.39 135.05 8.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 9' ' ' GLN . . . -170.71 138.97 5.24 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.211 -0.518 . . . . 0.0 112.01 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -141.06 141.69 34.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.868 ' SG ' HG13 ' A' ' 2' ' ' ILE . 1.7 t -149.73 127.08 11.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.06 -26.99 67.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.873 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.61 ' OG ' ' HG3' ' A' ' 35' ' ' ARG . 33.7 t -74.01 -40.07 63.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.659 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.62 47.12 12.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.539 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 28.9 t80 -144.91 70.77 1.28 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.9 m -68.62 80.09 0.28 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.803 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -70.63 94.63 1.02 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.823 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 61.1 tttm -141.85 44.98 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.344 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.595 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 74.2 mt-30 -68.65 -52.57 18.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.772 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 21.1 Cg_exo -66.78 157.93 58.77 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.174 1.916 . . . . 0.0 111.16 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.52 38.86 0.73 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 114.52 0.568 . . . . 0.0 114.52 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.823 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -81.41 151.03 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.639 0.719 . . . . 0.0 109.574 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.84 -46.45 91.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -108.14 119.4 39.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.26 139.96 17.18 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -122.46 157.43 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.928 0.864 . . . . 0.0 112.6 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 1.5 m -87.0 114.41 23.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -90.68 47.69 1.45 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.533 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.61 ' HG3' ' OG ' ' A' ' 19' ' ' SER . 13.5 ptm180 -177.19 -147.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.709 0.29 . . . . 0.0 110.72 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 tptm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.688 179.583 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.303 0.097 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.647 HG22 ' HB3' ' A' ' 6' ' ' ASN . 2.1 pp -45.34 129.4 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 O-C-N 123.732 0.645 . . . . 0.0 112.178 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -86.54 45.14 1.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 35' ' ' ARG . 81.1 m-20 53.4 38.37 27.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.094 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.36 33.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.429 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.647 ' HB3' HG22 ' A' ' 2' ' ' ILE . 26.2 t-20 -101.03 136.44 40.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.3 119.8 20.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.495 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.751 ' SG ' ' HG3' ' A' ' 14' ' ' GLN . 42.2 t -98.4 -53.36 3.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.529 0.204 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.0 101.34 16.62 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.128 0.49 . . . . 0.0 110.591 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 59.0 Cg_endo -72.82 -36.42 4.67 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.314 2.676 . . . . 0.0 112.71 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -158.41 56.68 0.45 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.039 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.61 40.17 54.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -145.8 80.23 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.751 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.2 tt0 -64.16 115.44 4.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.19 -67.24 1.76 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.582 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -177.12 149.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 0.0 110.343 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 2' ' ' ILE . 41.8 t -154.66 136.13 14.2 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.6 t -62.14 -45.94 91.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.141 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 p -89.86 -36.56 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.101 0.477 . . . . 0.0 110.919 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.69 19.31 60.09 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 29.3 t80 -96.8 56.94 1.51 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.642 0.734 . . . . 0.0 109.193 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.2 m -75.63 71.37 2.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.865 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 34' ' ' ARG . 6.6 p-80 -78.13 135.96 37.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.96 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.693 ' HB2' ' HE1' ' A' ' 28' ' ' TRP . 20.0 ptmt -164.26 148.43 9.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.16 0.505 . . . . 0.0 111.635 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -114.41 155.67 45.52 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.464 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.03 32.01 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.019 2.479 . . . . 0.0 113.705 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.99 -50.56 0.93 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.704 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.693 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 p90 -90.71 -176.07 4.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.632 0.253 . . . . 0.0 110.618 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.85 -79.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -92.93 134.63 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 24' ' ' LYS . . . -78.59 156.07 42.25 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -133.15 148.69 52.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.806 0.803 . . . . 0.0 111.76 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.605 ' HB2' HD13 ' A' ' 2' ' ' ILE . 57.1 m -73.49 138.62 45.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . 47.6 ttt180 -119.94 137.55 53.98 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 79.3 mtm180 -137.32 120.14 16.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.008 0.432 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.248 0.997 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.845 179.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.384 0.135 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.554 HG13 ' SG ' ' A' ' 18' ' ' CYS . 43.7 mt 64.52 48.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 122.188 0.994 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -141.1 135.91 31.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.637 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.705 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 19.7 p30 -66.74 138.06 57.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.29 46.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.101 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -66.67 130.51 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.75 134.53 44.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.345 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.3 p -132.59 -21.42 2.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.699 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.482 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 71.9 mm-40 -136.07 85.41 28.32 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 111.043 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 60.1 Cg_endo -74.26 76.22 3.14 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.867 2.378 . . . . 0.0 111.498 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.5 t30 75.3 -56.22 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.18 92.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 p -159.03 -58.51 0.07 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.63 0.252 . . . . 0.0 110.807 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -171.33 133.65 0.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.73 149.79 5.8 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -177.2 146.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 110.735 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.21 143.57 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.554 ' SG ' HG13 ' A' ' 2' ' ' ILE . 10.0 p -67.5 -52.83 34.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.916 0.326 . . . . 0.0 111.45 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.451 ' HB2' HD11 ' A' ' 2' ' ' ILE . 15.7 m -142.64 61.25 1.43 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -125.35 1.65 Allowed Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.03 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -160.33 117.97 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.584 0.231 . . . . 0.0 110.461 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 9' ' ' GLN . 48.8 t -82.98 145.64 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -143.71 120.73 11.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.243 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.659 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 50.8 tttp -157.88 125.54 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.593 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 88.3 mt-30 -121.34 -62.84 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 41.5 Cg_endo -85.24 -156.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.541 1.494 . . . . 0.0 110.327 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 -52.1 4.12 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.853 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 27.07 50.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.419 1.488 . . . . 0.0 114.51 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.4 t 70.75 -57.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.344 0.657 . . . . 0.0 111.849 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.73 146.6 2.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.611 0.243 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -63.92 140.59 44.09 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -123.78 148.68 46.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 112.241 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 85.8 m -70.37 132.15 45.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -98.21 22.84 8.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 72.01 -51.1 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.265 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.724 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.527 0.203 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.475 HD11 ' C ' ' A' ' 19' ' ' SER . 78.6 mt 70.16 120.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.943 0.777 . . . . 0.0 112.787 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -152.09 121.17 6.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 81.1 m-20 -77.06 60.25 1.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.393 0.616 . . . . 0.0 111.07 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.18 -40.48 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.707 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -63.83 134.74 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . -70.2 110.05 3.14 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.343 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 p -84.94 -38.27 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 0.0 109.594 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -123.71 77.37 56.43 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.713 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.533 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 3.9 Cg_exo -78.26 -44.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.526 2.818 . . . . 0.0 114.103 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -158.49 55.36 0.44 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.76 38.79 41.54 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.71 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.533 ' OG ' ' HD2' ' A' ' 10' ' ' PRO . 25.6 p -100.0 37.23 1.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 122.46 -0.435 . . . . 0.0 110.008 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 69.85 -59.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.164 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.77 -142.0 9.05 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.75 -138.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.51 64.06 1.94 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.4 m -38.28 -38.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.475 ' C ' HD11 ' A' ' 2' ' ' ILE . 9.1 t -138.34 45.77 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 110.031 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.41 -139.17 3.21 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.547 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.514 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 25.2 t80 -143.88 122.53 12.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.884 0.374 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 51.6 t -86.34 118.04 25.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -103.2 124.06 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.128 0.49 . . . . 0.0 111.196 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 9' ' ' GLN . 61.8 tttm -142.54 137.87 30.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -155.86 154.05 27.07 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.65 117.51 3.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.923 2.415 . . . . 0.0 112.527 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.54 -60.24 0.4 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.302 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.402 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.3 p90 -93.23 159.43 15.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.94 -49.69 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.793 0.33 . . . . 0.0 111.808 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -115.28 132.45 56.61 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . -75.17 150.34 40.5 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -127.41 155.66 43.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 118.003 0.901 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 64.8 m -64.02 133.32 52.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -123.82 51.14 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 64.78 -98.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.5 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 21' ' ' TYR . 26.8 tptp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.196 -0.906 . . . . 0.0 109.717 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.845 HG22 ' HD3' ' A' ' 35' ' ' ARG . 28.7 mt 67.71 72.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.093 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HE3' ' OD1' ' A' ' 6' ' ' ASN . 52.8 pttt -155.43 145.8 21.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -60.59 146.03 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.34 -38.78 3.06 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.989 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.401 ' OD1' ' HE3' ' A' ' 3' ' ' LYS . 3.3 m120 -69.09 136.48 52.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.68 0.276 . . . . 0.0 110.9 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.52 85.91 0.62 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 t -54.28 -44.29 71.77 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.224 0.61 . . . . 0.0 111.675 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 38.3 tt0 -145.52 87.89 6.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.658 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.38 -43.1 2.31 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.825 2.35 . . . . 0.0 111.739 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -159.69 40.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.52 42.21 99.72 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.597 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -64.43 -52.25 59.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.583 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -60.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.55 103.48 0.19 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.901 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.1 -50.3 64.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.265 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -86.66 144.94 26.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.57 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.451 ' HB2' HD11 ' A' ' 2' ' ' ILE . 14.6 m -73.3 71.75 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.874 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.7 m 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 109.715 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 18.12 54.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.955 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.2 t80 58.9 92.72 0.04 OUTLIER 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.07 0.938 . . . . 0.0 110.618 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.8 134.16 39.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.733 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.1 118.45 24.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.627 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 25.4 ttpp -136.59 124.82 23.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.622 0.725 . . . . 0.0 112.48 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.9 139.27 24.59 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.67 52.53 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.773 2.316 . . . . 0.0 113.339 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.5 39.58 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.128 -1.035 . . . . 0.0 114.183 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.627 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.5 OUTLIER -151.31 28.8 0.65 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.081 0.94 . . . . 0.0 112.429 178.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.4 t 67.8 -53.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.14 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.04 133.81 12.11 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.354 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -86.78 155.7 20.21 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.464 0.306 . . . . 0.0 110.802 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.35 122.18 23.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -83.14 66.21 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.071 0.462 . . . . 0.0 111.773 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.845 ' HD3' HG22 ' A' ' 2' ' ' ILE . 11.8 tpt180 -76.52 61.7 1.79 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.788 0.804 . . . . 0.0 109.6 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.142 -0.933 . . . . 0.0 109.831 -179.338 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.776 HG13 ' HG2' ' A' ' 35' ' ' ARG . 5.2 tp -83.34 112.11 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.319 0.58 . . . . 0.0 110.259 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -166.56 137.41 3.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.069 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 18.8 p30 -69.65 133.97 48.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -31.17 8.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.282 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.09 140.22 57.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.723 0.297 . . . . 0.0 110.337 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 95.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.525 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 11.9 t -83.25 -46.62 12.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.179 0.514 . . . . 0.0 109.636 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 83.2 mt-30 -140.57 79.38 20.16 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.225 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 30' ' ' ALA . 7.2 Cg_exo -74.31 51.48 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 113.518 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 t30 58.81 71.06 0.61 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 111.611 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.1 55.27 5.3 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.5 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 58.4 m -149.96 148.09 28.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -57.42 135.39 56.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 0.0 111.735 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.47 126.85 1.1 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -142.98 127.23 17.6 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 m -78.97 131.75 36.44 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB2' HG22 ' A' ' 2' ' ' ILE . 89.8 m -53.84 -46.52 71.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.9 p -72.68 -47.54 46.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.037 0.446 . . . . 0.0 110.33 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.9 2.14 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.489 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -66.16 126.99 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.369 0.604 . . . . 0.0 112.463 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.92 145.51 49.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.546 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -124.43 117.8 25.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.761 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 65.7 tttm -155.21 114.68 3.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.553 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 68.0 mt-30 -147.39 -51.98 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.503 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 24.5 Cg_exo -63.23 159.28 40.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.836 1.691 . . . . 0.0 111.442 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.57 45.47 2.4 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.762 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.761 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -78.74 167.39 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 111.068 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.5 -28.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.411 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -157.58 136.22 11.36 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 147.1 30.5 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -127.02 159.01 35.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.888 0.844 . . . . 0.0 112.867 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 58.0 m -78.67 178.76 7.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.281 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -159.83 133.62 7.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.776 ' HG2' HG13 ' A' ' 2' ' ' ILE . 75.7 mtp180 -84.72 -154.38 0.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.808 0.337 . . . . 0.0 110.566 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.134 179.348 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 10.3 t . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 74.9 mt 70.6 158.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 123.403 0.439 . . . . 0.0 111.787 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 2' ' ' ILE . 9.1 mtpm? 78.47 149.03 0.1 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.853 0.861 . . . . 0.0 112.292 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 77.9 m-20 -71.76 56.72 0.29 Allowed 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.388 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.55 0.12 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -161.86 145.9 12.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.12 137.02 50.68 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 123.568 0.542 . . . . 0.0 113.084 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 9' ' ' GLN . 9.3 t -140.88 -50.72 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.503 0.192 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.735 ' HG2' ' HA3' ' A' ' 15' ' ' GLY . 22.7 mt-30 -135.0 70.49 70.2 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.453 0.168 . . . . 0.0 111.18 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 18.1 Cg_endo -61.5 -39.25 56.89 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 123.072 2.515 . . . . 0.0 113.418 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -147.12 24.47 1.15 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.28 0.562 . . . . 0.0 111.387 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.1 30.96 77.93 Favored Glycine 0 CA--C 1.521 0.415 0 CA-C-N 115.547 -0.751 . . . . 0.0 114.908 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.0 m -83.2 58.81 4.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 117.603 0.702 . . . . 0.0 109.807 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 62.81 49.18 3.77 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.373 0.606 . . . . 0.0 109.397 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.735 ' HA3' ' HG2' ' A' ' 9' ' ' GLN . . . -60.75 134.09 49.6 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.111 -0.949 . . . . 0.0 112.776 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -157.77 127.75 6.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.872 0.368 . . . . 0.0 110.301 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.4 t -95.5 148.24 22.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.195 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.8 m -56.07 -34.92 66.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.223 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' HG12 ' A' ' 2' ' ' ILE . 12.0 p -63.78 -29.0 70.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.73 30.85 14.01 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 2.7 t80 -159.93 133.15 6.86 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.1 t -133.1 -171.76 2.76 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.963 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -164.56 118.58 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.845 0.355 . . . . 0.0 110.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.632 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 86.1 tttt -147.38 119.21 8.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.455 0.645 . . . . 0.0 110.72 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -94.8 149.75 36.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.276 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.73 57.45 1.47 Allowed 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 123.016 2.478 . . . . 0.0 112.519 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.43 -59.72 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.26 -0.495 . . . . 0.0 111.949 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.632 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -72.59 156.4 39.03 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.6 t -73.74 -63.75 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 120.937 0.399 . . . . 0.0 111.906 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.648 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -93.37 124.91 37.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.54 136.03 14.22 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.63 165.09 12.31 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.983 0.421 . . . . 0.0 111.953 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 98.0 m -70.61 169.91 13.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.847 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 26.4 ttp180 -151.36 142.22 22.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.684 ' HG3' ' HG2' ' A' ' 36' ' ' LYS . 38.8 ptt180 -99.3 -34.19 10.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.118 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.684 ' HG2' ' HG3' ' A' ' 35' ' ' ARG . 21.3 pttp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.801 -0.618 . . . . 0.0 110.138 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 32.7 t . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CG1' ' HB2' ' A' ' 18' ' ' CYS . 54.8 mt 74.66 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 O-C-N 123.433 0.458 . . . . 0.0 110.338 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.455 ' HG3' HG22 ' A' ' 2' ' ' ILE . 30.1 mtpp 74.94 148.53 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.184 0.594 . . . . 0.0 110.434 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 66.2 m-80 -59.64 137.93 57.88 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.324 -178.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 32' ' ' TYR . . . 135.09 -46.91 1.01 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.582 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 10.1 t-20 -63.33 126.43 27.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.552 -0.324 . . . . 0.0 110.903 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.99 76.94 1.86 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.544 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 21.7 p -69.3 -44.34 71.99 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.587 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 4.2 tp60 -129.08 82.28 68.9 Favored Pre-proline 0 C--N 1.321 -0.648 0 C-N-CA 121.044 -0.263 . . . . 0.0 111.57 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 38.1 Cg_exo -57.86 -42.33 60.0 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.494 2.129 . . . . 0.0 110.971 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -162.64 -31.93 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.823 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.59 55.1 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.226 -0.987 . . . . 0.0 112.908 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.1 p -95.42 -58.22 2.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.591 0.195 . . . . 0.0 110.614 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 176.59 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 O-C-N 123.614 0.571 . . . . 0.0 111.294 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' A' ' 8' ' ' CYS . . . 81.03 53.5 3.91 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -76.03 54.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.0 m -70.73 134.73 47.71 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . 55.6 m -69.75 -22.69 63.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.4 p -173.77 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.673 0.273 . . . . 0.0 111.329 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 21' ' ' TYR . . . -50.59 -20.87 4.22 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.05 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 20' ' ' GLY . 4.0 t80 72.81 115.08 0.06 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-O 121.528 0.68 . . . . 0.0 110.429 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 31.8 t -67.96 135.51 52.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.125 -178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -142.54 129.37 20.55 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.56 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.656 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 27.2 ttpp -140.02 120.97 14.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.264 0.554 . . . . 0.0 111.684 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -85.6 144.77 40.56 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.91 56.3 1.87 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.622 2.215 . . . . 0.0 113.205 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -173.53 34.28 0.12 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.118 -1.039 . . . . 0.0 114.23 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.625 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -158.75 12.12 0.16 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 117.998 0.899 . . . . 0.0 112.089 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.2 m 31.26 44.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -179.09 106.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.128 0.489 . . . . 0.0 111.138 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -86.62 151.26 24.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.656 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -135.82 159.69 40.87 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.98 0.419 . . . . 0.0 111.413 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 62.3 m -66.73 129.18 39.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.294 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.7 -144.35 0.08 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 -141.42 138.72 33.13 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.541 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.531 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 49.8 t . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.564 HG12 ' HA2' ' A' ' 20' ' ' GLY . 26.7 mt -65.57 119.51 10.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 O-C-N 122.212 -0.305 . . . . 0.0 111.491 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.8 ttpp -153.55 24.68 0.52 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.189 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 59.08 121.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.797 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.816 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 65.04 23.01 69.28 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.622 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' TYR . 6.1 t-20 -84.68 162.87 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.34 88.37 0.1 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.192 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.82 -33.67 24.86 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.568 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 7.3 tt0 -154.79 64.55 4.39 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.629 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD2' ' O ' ' A' ' 14' ' ' GLN . 73.0 Cg_endo -77.57 -44.83 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.759 2.306 . . . . 0.0 112.832 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -80.26 -32.78 38.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.617 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.62 -35.93 3.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.597 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.4 m -68.29 -50.52 53.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 109.881 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.568 ' O ' ' HA ' ' A' ' 9' ' ' GLN . 18.9 tt0 -169.46 -142.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.03 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.11 -139.79 2.72 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.705 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -137.42 42.06 2.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 111.793 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.2 m -122.68 117.93 26.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.9 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -48.95 78.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.667 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -153.71 45.93 0.62 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA2' HG12 ' A' ' 2' ' ' ILE . . . -73.64 -7.81 75.15 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 114.283 -1.326 . . . . 0.0 114.136 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.601 ' HB3' ' O ' ' A' ' 34' ' ' ARG . 14.5 t80 67.31 74.08 0.32 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.524 0.678 . . . . 0.0 109.331 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 74.5 m -59.81 124.41 20.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.281 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -120.47 120.14 35.03 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 57.2 tttm -147.3 127.65 13.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.106 0.479 . . . . 0.0 110.281 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -141.46 155.85 67.14 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.487 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.5 113.65 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.662 2.241 . . . . 0.0 111.58 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 155.01 -47.13 0.52 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.538 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 2.0 p90 -110.78 151.17 28.1 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.94 -38.28 18.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.01 127.63 54.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.7 134.11 14.71 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.816 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 20.0 p90 -104.66 152.23 22.73 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.422 ' HB3' ' HA3' ' A' ' 20' ' ' GLY . 3.9 m -81.8 118.11 22.63 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.601 ' O ' ' HB3' ' A' ' 21' ' ' TYR . 79.2 ttt180 -107.45 132.92 52.68 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.465 -0.198 . . . . 0.0 110.465 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -66.56 109.55 2.83 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.853 -179.033 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.673 HG22 ' HG2' ' A' ' 35' ' ' ARG . 27.1 mt 66.72 47.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 122.041 0.924 . . . . 0.0 109.899 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -88.89 131.37 35.15 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.427 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.64 62.64 0.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.277 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.33 -28.24 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.134 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -52.42 133.14 35.31 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 122.537 0.335 . . . . 0.0 110.72 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.01 83.42 0.72 Allowed Glycine 0 C--N 1.332 0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.457 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.83 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 40.5 t -81.04 -39.06 26.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.877 0.37 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -127.02 71.94 75.99 Favored Pre-proline 0 C--N 1.324 -0.505 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.695 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 10.1 Cg_exo -72.45 -52.0 0.19 Allowed 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.793 2.329 . . . . 0.0 112.103 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -160.67 36.47 0.16 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.892 0.377 . . . . 0.0 111.188 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.04 43.72 88.22 Favored Glycine 0 CA--C 1.519 0.299 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.39 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.3 t -126.63 -35.93 2.29 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 122.823 -0.222 . . . . 0.0 110.613 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -167.7 128.95 1.48 Allowed 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.175 0.512 . . . . 0.0 111.012 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 8' ' ' CYS . . . 169.68 138.18 2.43 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -163.21 138.96 6.81 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.269 0.534 . . . . 0.0 111.137 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 m -140.31 140.58 35.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -51.03 -36.08 37.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.448 ' H ' HG12 ' A' ' 2' ' ' ILE . 25.5 p -68.27 -35.01 77.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.75 36.35 91.08 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 9.4 t80 -136.67 58.41 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.679 0.752 . . . . 0.0 109.601 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.6 m -82.38 136.0 35.06 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.012 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -114.57 134.75 54.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.863 0.363 . . . . 0.0 111.301 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 85.0 tttt -135.27 147.48 49.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.548 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 26' ' ' PRO . 6.7 tt0 -145.67 145.1 24.4 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 25' ' ' GLN . 38.3 Cg_endo -66.37 48.03 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.283 2.656 . . . . 0.0 113.239 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.76 16.65 2.2 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.472 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.5 p90 -167.24 154.05 8.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.47 -56.79 8.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -107.42 133.0 52.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.99 128.11 8.3 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.425 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -80.53 152.82 28.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.215 0.531 . . . . 0.0 112.035 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 78.3 m -76.93 131.8 38.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.35 179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 59.3 mtp180 -101.75 148.54 25.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.057 0.456 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' A' ' 2' ' ' ILE . 73.0 mtp180 -92.56 -38.77 11.73 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.971 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.504 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.38 0.133 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.868 HG13 ' SG ' ' A' ' 17' ' ' CYS . 29.2 mm -50.57 146.03 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 6' ' ' ASN . 24.6 ttmm -145.96 165.55 28.64 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.404 ' N ' ' HG2' ' A' ' 3' ' ' LYS . 5.5 t-20 -67.75 67.43 0.1 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.043 0.838 . . . . 0.0 111.241 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.9 -20.28 0.21 Allowed Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' A' ' 3' ' ' LYS . 3.6 m120 -63.65 136.24 57.35 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.085 0.469 . . . . 0.0 111.184 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -55.74 139.94 41.85 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.942 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 34.6 t -113.9 -42.82 3.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.939 -0.63 . . . . 0.0 110.349 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.577 ' HA ' ' HA3' ' A' ' 15' ' ' GLY . 2.3 mm100 -154.36 77.19 5.47 Favored Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 12.5 Cg_exo -68.99 124.12 11.06 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.468 2.112 . . . . 0.0 111.042 179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 69.38 -57.06 0.54 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.884 0.874 . . . . 0.0 111.338 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 137.19 -25.15 3.05 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.1 m -59.99 -39.19 84.91 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 111.904 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.459 ' O ' ' HD2' ' A' ' 10' ' ' PRO . 23.5 tp60 -159.39 135.05 8.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 9' ' ' GLN . . . -170.71 138.97 5.24 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.211 -0.518 . . . . 0.0 112.01 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -141.06 141.69 34.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.592 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.868 ' SG ' HG13 ' A' ' 2' ' ' ILE . 1.7 t -149.73 127.08 11.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.06 -26.99 67.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.873 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.61 ' OG ' ' HG3' ' A' ' 35' ' ' ARG . 33.7 t -74.01 -40.07 63.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.659 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.62 47.12 12.72 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.539 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.565 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 28.9 t80 -144.91 70.77 1.28 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 65.9 m -68.62 80.09 0.28 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.803 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -70.63 94.63 1.02 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.823 ' HA ' ' HE1' ' A' ' 28' ' ' TRP . 61.1 tttm -141.85 44.98 1.7 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.344 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.595 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 74.2 mt-30 -68.65 -52.57 18.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.772 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 21.1 Cg_exo -66.78 157.93 58.77 Favored 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 122.174 1.916 . . . . 0.0 111.16 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.52 38.86 0.73 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 114.52 0.568 . . . . 0.0 114.52 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.823 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -81.41 151.03 28.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.639 0.719 . . . . 0.0 109.574 178.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -64.84 -46.45 91.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -108.14 119.4 39.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -86.26 139.96 17.18 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.219 -1.553 . . . . 0.0 109.219 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -122.46 157.43 31.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 117.928 0.864 . . . . 0.0 112.6 -177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 21' ' ' TYR . 1.5 m -87.0 114.41 23.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -90.68 47.69 1.45 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.533 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.61 ' HG3' ' OG ' ' A' ' 19' ' ' SER . 13.5 ptm180 -177.19 -147.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.709 0.29 . . . . 0.0 110.72 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.8 tptm . . . . . 0 C--O 1.249 1.03 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.688 179.583 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.303 0.097 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.647 HG22 ' HB3' ' A' ' 6' ' ' ASN . 2.1 pp -45.34 129.4 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 O-C-N 123.732 0.645 . . . . 0.0 112.178 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -86.54 45.14 1.21 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 35' ' ' ARG . 81.1 m-20 53.4 38.37 27.76 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.094 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.36 33.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.429 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.647 ' HB3' HG22 ' A' ' 2' ' ' ILE . 26.2 t-20 -101.03 136.44 40.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.3 119.8 20.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.495 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.751 ' SG ' ' HG3' ' A' ' 14' ' ' GLN . 42.2 t -98.4 -53.36 3.36 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.529 0.204 . . . . 0.0 110.573 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.0 101.34 16.62 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.128 0.49 . . . . 0.0 110.591 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' ALA . 59.0 Cg_endo -72.82 -36.42 4.67 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.314 2.676 . . . . 0.0 112.71 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -158.41 56.68 0.45 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.039 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.61 40.17 54.31 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 m -145.8 80.23 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.751 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.2 tt0 -64.16 115.44 4.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.19 -67.24 1.76 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.582 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -177.12 149.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.899 0.381 . . . . 0.0 110.343 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 2' ' ' ILE . 41.8 t -154.66 136.13 14.2 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 4.6 t -62.14 -45.94 91.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.141 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 p -89.86 -36.56 15.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.101 0.477 . . . . 0.0 110.919 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.69 19.31 60.09 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' CYS . 29.3 t80 -96.8 56.94 1.51 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.642 0.734 . . . . 0.0 109.193 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.2 m -75.63 71.37 2.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.865 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 34' ' ' ARG . 6.6 p-80 -78.13 135.96 37.77 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.96 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.693 ' HB2' ' HE1' ' A' ' 28' ' ' TRP . 20.0 ptmt -164.26 148.43 9.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.16 0.505 . . . . 0.0 111.635 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -114.41 155.67 45.52 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.464 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.03 32.01 0.17 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.019 2.479 . . . . 0.0 113.705 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.99 -50.56 0.93 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.073 -0.584 . . . . 0.0 111.704 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.693 ' HE1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 p90 -90.71 -176.07 4.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.632 0.253 . . . . 0.0 110.618 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.85 -79.58 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 10' ' ' PRO . . . -92.93 134.63 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.566 ' HA3' ' HB3' ' A' ' 24' ' ' LYS . . . -78.59 156.07 42.25 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -133.15 148.69 52.1 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 117.806 0.803 . . . . 0.0 111.76 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.605 ' HB2' HD13 ' A' ' 2' ' ' ILE . 57.1 m -73.49 138.62 45.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.441 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.475 ' HB2' ' CE1' ' A' ' 23' ' ' HIS . 47.6 ttt180 -119.94 137.55 53.98 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' HB2' ' OD1' ' A' ' 4' ' ' ASN . 79.3 mtm180 -137.32 120.14 16.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.008 0.432 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.248 0.997 0 CA-C-O 117.863 -1.065 . . . . 0.0 108.845 179.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.384 0.135 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.554 HG13 ' SG ' ' A' ' 18' ' ' CYS . 43.7 mt 64.52 48.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 122.188 0.994 . . . . 0.0 109.902 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -141.1 135.91 31.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.637 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.705 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 19.7 p30 -66.74 138.06 57.11 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.141 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.44 -21.29 46.4 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.101 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -66.67 130.51 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.75 134.53 44.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.132 -0.556 . . . . 0.0 113.345 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.547 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 25.3 p -132.59 -21.42 2.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.774 0.321 . . . . 0.0 110.699 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.482 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 71.9 mm-40 -136.07 85.41 28.32 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 111.043 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 11' ' ' ASN . 60.1 Cg_endo -74.26 76.22 3.14 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.867 2.378 . . . . 0.0 111.498 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.5 t30 75.3 -56.22 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.08 -178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.18 92.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.5 p -159.03 -58.51 0.07 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.63 0.252 . . . . 0.0 110.807 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -171.33 133.65 0.85 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.73 149.79 5.8 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.086 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -177.2 146.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 110.735 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 m -74.21 143.57 45.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.554 ' SG ' HG13 ' A' ' 2' ' ' ILE . 10.0 p -67.5 -52.83 34.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.916 0.326 . . . . 0.0 111.45 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.451 ' HB2' HD11 ' A' ' 2' ' ' ILE . 15.7 m -142.64 61.25 1.43 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.99 0.424 . . . . 0.0 109.892 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -146.66 -125.35 1.65 Allowed Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.03 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -160.33 117.97 2.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.584 0.231 . . . . 0.0 110.461 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 9' ' ' GLN . 48.8 t -82.98 145.64 29.23 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -143.71 120.73 11.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.042 0.449 . . . . 0.0 111.243 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.659 ' HB2' ' HA3' ' A' ' 31' ' ' GLY . 50.8 tttp -157.88 125.54 5.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.978 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.593 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 88.3 mt-30 -121.34 -62.84 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 41.5 Cg_endo -85.24 -156.67 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 121.541 1.494 . . . . 0.0 110.327 177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 -52.1 4.12 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.853 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HZ2' ' HA ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 27.07 50.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.419 1.488 . . . . 0.0 114.51 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.4 t 70.75 -57.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 123.344 0.657 . . . . 0.0 111.849 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -171.73 146.6 2.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.611 0.243 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 24' ' ' LYS . . . -63.92 140.59 44.09 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -123.78 148.68 46.44 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.144 0.497 . . . . 0.0 112.241 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.705 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 85.8 m -70.37 132.15 45.19 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -98.21 22.84 8.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 72.01 -51.1 0.7 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.265 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.724 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.527 0.203 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.475 HD11 ' C ' ' A' ' 19' ' ' SER . 78.6 mt 70.16 120.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 O-C-N 123.943 0.777 . . . . 0.0 112.787 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -152.09 121.17 6.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 81.1 m-20 -77.06 60.25 1.82 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.393 0.616 . . . . 0.0 111.07 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.18 -40.48 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.707 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -63.83 134.74 55.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 31' ' ' GLY . . . -70.2 110.05 3.14 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.825 -0.625 . . . . 0.0 113.343 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.5 p -84.94 -38.27 19.53 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 0.0 109.594 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 24' ' ' LYS . 0.7 OUTLIER -123.71 77.37 56.43 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.713 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.533 ' HD2' ' OG ' ' A' ' 13' ' ' SER . 3.9 Cg_exo -78.26 -44.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 123.526 2.818 . . . . 0.0 114.103 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -158.49 55.36 0.44 Allowed 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.76 38.79 41.54 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.886 -0.597 . . . . 0.0 113.71 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.533 ' OG ' ' HD2' ' A' ' 10' ' ' PRO . 25.6 p -100.0 37.23 1.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 122.46 -0.435 . . . . 0.0 110.008 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 69.85 -59.8 0.49 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.164 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.77 -142.0 9.05 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -176.75 -138.65 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 3.2 m 54.51 64.06 1.94 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 21.4 m -38.28 -38.7 0.37 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.475 ' C ' HD11 ' A' ' 2' ' ' ILE . 9.1 t -138.34 45.77 2.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.372 0.606 . . . . 0.0 110.031 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.41 -139.17 3.21 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.547 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.514 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 25.2 t80 -143.88 122.53 12.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.884 0.374 . . . . 0.0 111.277 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 9' ' ' GLN . 51.6 t -86.34 118.04 25.53 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -103.2 124.06 47.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.128 0.49 . . . . 0.0 111.196 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 9' ' ' GLN . 61.8 tttm -142.54 137.87 30.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.864 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -155.86 154.05 27.07 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.65 117.51 3.76 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.923 2.415 . . . . 0.0 112.527 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 152.54 -60.24 0.4 Allowed Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.302 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.402 ' HE1' ' HA ' ' A' ' 24' ' ' LYS . 1.3 p90 -93.23 159.43 15.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.94 -49.69 27.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.793 0.33 . . . . 0.0 111.808 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -115.28 132.45 56.61 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' O ' ' HA2' ' A' ' 7' ' ' GLY . . . -75.17 150.34 40.5 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -127.41 155.66 43.3 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 118.003 0.901 . . . . 0.0 111.538 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 64.8 m -64.02 133.32 52.9 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -123.82 51.14 1.55 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 64.78 -98.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.5 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 21' ' ' TYR . 26.8 tptp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.196 -0.906 . . . . 0.0 109.717 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.617 -0.142 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.845 HG22 ' HD3' ' A' ' 35' ' ' ARG . 28.7 mt 67.71 72.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.093 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HE3' ' OD1' ' A' ' 6' ' ' ASN . 52.8 pttt -155.43 145.8 21.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.701 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -60.59 146.03 46.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.34 -38.78 3.06 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.989 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.401 ' OD1' ' HE3' ' A' ' 3' ' ' LYS . 3.3 m120 -69.09 136.48 52.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.68 0.276 . . . . 0.0 110.9 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.52 85.91 0.62 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 t -54.28 -44.29 71.77 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.224 0.61 . . . . 0.0 111.675 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 38.3 tt0 -145.52 87.89 6.8 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.658 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.38 -43.1 2.31 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.825 2.35 . . . . 0.0 111.739 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -159.69 40.29 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.869 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.52 42.21 99.72 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.597 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -64.43 -52.25 59.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.718 0.294 . . . . 0.0 110.583 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.41 -60.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 159.55 103.48 0.19 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.901 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.1 -50.3 64.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.162 0.506 . . . . 0.0 110.265 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -86.66 144.94 26.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.57 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.451 ' HB2' HD11 ' A' ' 2' ' ' ILE . 14.6 m -73.3 71.75 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.874 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.7 m 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.389 0.614 . . . . 0.0 109.715 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.11 18.12 54.86 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.659 -0.781 . . . . 0.0 111.955 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.2 t80 58.9 92.72 0.04 OUTLIER 'General case' 0 C--O 1.236 0.37 0 CA-C-O 122.07 0.938 . . . . 0.0 110.618 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 61.5 m -76.8 134.16 39.18 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.733 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.1 118.45 24.41 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.627 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 25.4 ttpp -136.59 124.82 23.14 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.622 0.725 . . . . 0.0 112.48 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -91.9 139.27 24.59 Favored Pre-proline 0 C--N 1.316 -0.858 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.67 52.53 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.773 2.316 . . . . 0.0 113.339 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.5 39.58 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.128 -1.035 . . . . 0.0 114.183 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.627 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.5 OUTLIER -151.31 28.8 0.65 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.081 0.94 . . . . 0.0 112.429 178.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 86.4 t 67.8 -53.27 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.37 143.14 25.57 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.04 133.81 12.11 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.354 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -86.78 155.7 20.21 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 122.464 0.306 . . . . 0.0 110.802 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.5 m -75.35 122.18 23.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -83.14 66.21 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.071 0.462 . . . . 0.0 111.773 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.845 ' HD3' HG22 ' A' ' 2' ' ' ILE . 11.8 tpt180 -76.52 61.7 1.79 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.788 0.804 . . . . 0.0 109.6 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.142 -0.933 . . . . 0.0 109.831 -179.338 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.776 HG13 ' HG2' ' A' ' 35' ' ' ARG . 5.2 tp -83.34 112.11 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.319 0.58 . . . . 0.0 110.259 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -166.56 137.41 3.36 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.069 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 18.8 p30 -69.65 133.97 48.17 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.08 -31.17 8.76 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.282 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -60.09 140.22 57.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.723 0.297 . . . . 0.0 110.337 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.03 95.29 0.2 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.525 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 11.9 t -83.25 -46.62 12.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.179 0.514 . . . . 0.0 109.636 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.471 ' HB2' ' HD2' ' A' ' 24' ' ' LYS . 83.2 mt-30 -140.57 79.38 20.16 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.225 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' CB ' ' A' ' 30' ' ' ALA . 7.2 Cg_exo -74.31 51.48 2.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 113.518 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.5 t30 58.81 71.06 0.61 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.256 0.551 . . . . 0.0 111.611 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.1 55.27 5.3 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.5 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.456 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 58.4 m -149.96 148.09 28.66 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -57.42 135.39 56.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.331 0.586 . . . . 0.0 111.735 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -178.47 126.85 1.1 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -142.98 127.23 17.6 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.9 m -78.97 131.75 36.44 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB2' HG22 ' A' ' 2' ' ' ILE . 89.8 m -53.84 -46.52 71.25 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.9 p -72.68 -47.54 46.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.037 0.446 . . . . 0.0 110.33 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.27 -34.9 2.14 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.489 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -66.16 126.99 30.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.369 0.604 . . . . 0.0 112.463 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.4 t -133.92 145.51 49.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.546 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -124.43 117.8 25.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.166 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.761 ' HG3' ' HE1' ' A' ' 28' ' ' TRP . 65.7 tttm -155.21 114.68 3.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.056 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.553 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 68.0 mt-30 -147.39 -51.98 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.503 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 25' ' ' GLN . 24.5 Cg_exo -63.23 159.28 40.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 121.836 1.691 . . . . 0.0 111.442 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.57 45.47 2.4 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.762 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.761 ' HE1' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -78.74 167.39 21.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.827 0.346 . . . . 0.0 111.068 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.5 -28.78 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.411 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 10' ' ' PRO . . . -157.58 136.22 11.36 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.74 147.1 30.5 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -127.02 159.01 35.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.888 0.844 . . . . 0.0 112.867 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 58.0 m -78.67 178.76 7.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.281 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 ttt85 -159.83 133.62 7.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.776 ' HG2' HG13 ' A' ' 2' ' ' ILE . 75.7 mtp180 -84.72 -154.38 0.18 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.808 0.337 . . . . 0.0 110.566 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.4 pttp . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.134 179.348 . . . . . . . . 0 0 . 1 stop_ save_